No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
11384 |
6. Filter based on genotype QC (FinnGen only) |
11384 |
Control definitions (FinnGen only)
- Control exclude
- THYROID_DISORDER_IBD
Extra metadata
- First used in FinnGen datafreeze
- DF2
Thyrotoxicosis
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 77269 | 61676 | 14979 |
| Only index persons | 67659 | 54737 | 12922 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.50 | 1.77 | 0.42 |
| Only index persons | 1.72 | 2.01 | 0.49 |
| Median age at first event (years) | |||
| Whole population | 54.48 | 53.92 | 57.07 |
| Only index persons | 52.97 | 52.26 | 55.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 11384 | 9028 | 2356 |
| Unadjusted period prevalence (%) | 2.66 | 3.08 | 1.04 |
| Median age at first event (years) | 52.46 | 50.64 | 59.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 10169
- Matched controls
- 101701
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E05.89
ICD-10 Finland
Other thyrotoxicosis
699.3
323.0
404
6
C07AB07
ATC
bisoprolol; oral
2.3
323.0
5152
31812
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
1697.2
323.0
4487
47
104
Kela drug reimbursment
Thyroid insufficiency
7.6
323.0
2376
3910
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
222.4
323.0
1039
52
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
39.5
323.0
670
181
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
15.2
323.0
664
465
T85
ICPC
Hyperthyroidism/thyrotoxicosis
45.9
323.0
402
91
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
24.9
323.0
1042
464
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
6332.4
323.0
5205
15
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
182.2
323.0
1076
66
H03AA01
ATC
levothyroxine sodium; systemic
7.9
323.0
6144
16450
H03BB01
ATC
carbimazole; oral
1441.7
323.0
6979
154
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
292.2
323.0
880
33
BAA60
NOMESCO Finland
Total thyroidectomy
21.9
323.0
1467
775
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
323.0
678
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
1021.1
323.0
1633
19
C07AA05
ATC
propranolol; systemic
3.6
323.0
3461
12615
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
+∞
308.9
295
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.9
275.3
1945
7623
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
+∞
273.1
261
*
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
2417.7
255.0
246
*
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
42.2
237.3
299
73
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.9
214.0
969
2685
H062, E050
ICD-10 Finland
NA
+∞
203.8
195
*
C01BD01
ATC
amiodarone; systemic
6.4
184.6
512
834
24209
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffuse NUD
+∞
183.9
176
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
8.4
170.2
391
482
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
+∞
168.2
161
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
4.3
163.5
645
1563
T86
ICPC
Hypothyroidism/myxoedema
3.8
146.4
670
1854
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
+∞
145.1
139
*
H03BA02
ATC
propylthiouracil; oral
+∞
142.0
136
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
3.7
137.8
651
1849
24220
ICD-8 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre
+∞
129.4
124
*
E03
ICD-10 Finland
Other hypothyroidism
2.9
125.9
861
3193
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
123.3
3566
24436
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
33.2
120.9
160
49
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
120.0
115
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
6.1
113.4
324
546
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.8
113.1
513
1403
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.9
108.0
1916
11129
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
107.6
107.2
117
11
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
106.0
4257
31519
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
21.6
102.7
153
72
TFP20
NOMESCO Finland
Cardiodefibrillation
2.7
100.1
728
2790
E06.3
ICD-10 Finland
Autoimmune thyroiditis
17.4
99.1
159
93
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
4.3
95.5
376
904
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
14.9
86.0
146
99
E05.5
ICD-10 Finland
Thyroid crisis or storm
+∞
84.5
81
*
E06.9
ICD-10 Finland
Thyroiditis, unspecified
36.0
82.7
107
30
H05.2
ICD-10 Finland
Exophthalmic conditions
21.9
81.8
121
56
207
Kela drug reimbursment
Chronic arrhythmias
1.9
81.4
1260
6893
C07AA07
ATC
sotalol; systemic
3.3
77.6
422
1330
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
7.8
72.2
171
222
H02AB06
ATC
prednisolone; systemic
1.5
69.4
4381
34749
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
3.8
68.9
306
820
C07AB02
ATC
metoprolol; systemic
1.6
66.3
1865
12262
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
26.9
63.4
88
33
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
61.2
3758
29404
B01AA03
ATC
warfarin; systemic
1.7
59.7
1563
10044
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
293.6
57.3
58
*
A11CC03
ATC
alfacalcidol; systemic
3.7
56.8
260
716
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
16.5
55.5
90
55
2422A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic multinodular goitre
+∞
55.2
53
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
53.7
1403
8986
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
52.0
1134
6890
C01AA05
ATC
digoxin; systemic
2.1
51.8
644
3207
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.3
51.3
126
174
E06.4
ICD-10 Finland
Drug-induced thyroiditis
500.4
50.4
50
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
49.1
1981
14081
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
4.4
49.0
186
433
C03CA01
ATC
furosemide; systemic
1.5
48.1
2282
16776
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.4
47.6
412
1731
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.7
47.3
218
605
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
241.1
47.0
48
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
47.0
1001
6028
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
46.8
1777
12442
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
45.9
981
5912
TFP34
NOMESCO Finland
Electrophysiological investigation
2.9
45.4
293
1039
R00.2
ICD-10 Finland
Palpitations
1.9
44.7
701
3813
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
44.4
1689
11819
H03BB02
ATC
thiamazole; oral
115.5
42.7
46
*
CA1AD
NOMESCO Finland
Orbita CT
15.6
42.5
70
45
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
42.0
2327
17557
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
41.5
1043
6577
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
40.6
935
5752
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
40.5
1310
8810
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.1
40.4
504
2509
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
4.8
40.2
138
291
H53.2
ICD-10 Finland
Diplopia
2.6
39.2
292
1131
XF404
NOMESCO Finland
Ambulatory ECG
1.8
38.5
768
4524
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
4.4
38.4
144
333
N02BE01
ATC
paracetamol; systemic, rectal
1.4
38.1
8282
77088
106
Kela drug reimbursment
Hypoparathyroidism
8.0
37.9
87
109
A02BC02
ATC
pantoprazole; systemic
1.3
37.9
5961
52760
I47.2
ICD-10 Finland
Ventricular tachycardia
3.3
37.6
193
585
TFP35
NOMESCO Finland
Electroanatomical mapping
3.9
37.1
156
402
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
37.0
1397
9720
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.7
36.5
260
980
R94.6
ICD-10 Finland
Abnormal results of thyroid function studies
7.0
36.2
91
131
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.0
36.2
476
2421
C01BC04
ATC
flecainide; systemic
2.4
35.6
312
1319
H50.2
ICD-10 Finland
Vertical strabismus
5.3
34.6
108
206
ZXA10
NOMESCO Finland
Bilateral
1.4
34.4
1607
11673
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
33.9
2416
18924
CAC44
NOMESCO Finland
Combined decompression of orbit
328.2
32.9
33
*
E83.51
ICD-10 Finland
Hypocalcemia
6.0
32.4
91
153
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.1
32.3
367
1757
R53
ICD-10 Finland
Malaise and fatigue
1.4
31.8
1772
13285
E05.3
ICD-10 Finland
Thyrotoxicosis from ectopic thyroid tissue
+∞
30.2
29
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.1
30.2
365
1794
ZX120
NOMESCO Finland
Intravenous
1.6
29.9
770
4870
B01AF02
ATC
apixaban; oral
1.7
29.9
725
4510
K78
ICPC
Atrial fibrillation/flutter
1.8
29.8
554
3188
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
29.7
444
2373
K80
ICPC
Cardiac arrhythmia NOS
1.7
29.3
628
3773
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.2
29.3
308
1426
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
3.1
29.2
162
522
2423X
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre, unspecified
+∞
29.2
28
*
K04
ICPC
Palpitations/awareness of heart
1.9
29.2
457
2481
R06.0
ICD-10 Finland
Dyspnoea
1.4
29.0
2047
15943
H04AA01
ATC
glucagon; nasal, parenteral
2.6
28.9
210
804
H02AB07
ATC
prednisone; oral
1.5
28.8
1227
8722
C03DA01
ATC
spironolactone; oral
1.6
28.2
811
5277
WX402
NOMESCO Finland
General anaesthesia
1.4
28.2
1367
9968
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.4
28.0
242
1019
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
27.6
1448
10709
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
10.2
27.3
54
53
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
4.2
27.3
105
251
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
26.7
2139
16958
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
26.4
3508
29798
A11CC02
ATC
dihydrotachysterol; oral
7.9
26.3
60
76
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
135.3
25.6
27
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
25.6
881
5979
T89
ICPC
Diabetes insulin dependent
2.1
25.2
307
1513
R03AC02
ATC
salbutamol; inhalant
1.2
24.5
4681
41374
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
9.8
24.4
49
50
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.9
23.8
364
1961
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
23.8
546
3345
CAC20
NOMESCO Finland
Lateral decompression of orbit
125.3
23.6
25
*
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
23.2
759
5088
H02AB09
ATC
hydrocortisone; systemic
2.4
23.2
201
850
XCK00
NOMESCO Finland
Perimetry
1.7
22.8
540
3335
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.4
22.8
192
800
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
22.7
1008
7205
H50.6
ICD-10 Finland
Mechanical strabismus
25.9
22.6
31
12
C09AA05
ATC
ramipril; oral
1.3
22.5
1720
13491
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.5
22.4
184
756
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
2.5
22.1
175
705
E06.0
ICD-10 Finland
Acute thyroiditis
23.9
22.1
31
13
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.2
22.0
218
982
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.0
21.9
287
1461
A10AE04
ATC
insulin glargine; parenteral
1.6
21.9
653
4278
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
21.9
21
*
E05.8
ICD-10 Finland
Other thyrotoxicosis
+∞
21.9
21
*
M14.5*E05.9
ICD-10 Finland
Arthropathy in thyrotoxicosis [hyperthyroidism]
220.4
21.6
22
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
2.8
21.5
137
487
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
21.5
2567
21381
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
21.4
314
1665
SPAT1262
SPAT
Handing over of treatment supplies
1.4
21.3
1341
10196
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
3.0
21.1
124
419
E05.81
ICD-10 Finland
Overproduction of thyroid-stimulating hormone
+∞
20.8
20
*
J01DB01
ATC
cefalexin; oral
1.3
20.8
7587
71325
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.0
20.6
261
1308
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
20.6
3051
26040
I50.1
ICD-10 Finland
Left ventricular failure
2.0
20.6
285
1481
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
20.6
555
3549
A04
ICPC
Weakness/tiredness general
1.4
20.5
1043
7641
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
20.4
1728
13739
A10AA01
ATC
NA
2.1
20.4
221
1041
A10AE05
ATC
insulin detemir; parenteral
1.7
20.4
399
2331
WX892
NOMESCO Finland
Monitored bed care
1.6
20.3
532
3375
O90.5
ICD-10 Finland
Postpartum thyroiditis
22.4
20.3
29
13
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
20.2
4580
40893
E89.9
ICD-10 Finland
Postprocedural endocrine and metabolic disorder, unspecified
32.6
20.1
26
8
J01AA02
ATC
doxycycline; systemic
1.2
20.1
7216
67539
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.1
20.0
79
196
WX110
NOMESCO Finland
Local anesthesy
1.2
19.9
6127
56389
2421A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic uninodular goitre
+∞
19.8
19
*
BA1AN
NOMESCO Finland
Thyroid gland isotope imaging
+∞
19.8
19
*
I50.0
ICD-10 Finland
Congestive heart failure
1.7
19.1
440
2698
B01AB05
ATC
enoxaparin; parenteral
1.3
18.9
2490
20927
T81
ICPC
Goitre
4.9
18.9
61
124
J01DA01
ATC
[U] cefalexin; systemic
1.2
18.9
5651
51718
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
3.1
18.6
103
335
342
Kela drug reimbursment
Dronedarone
3.8
18.6
80
214
A10AA02
ATC
NA
1.9
18.5
260
1362
AA1AD
NOMESCO Finland
CT of head and brain
1.3
18.5
1755
14155
TFP47
NOMESCO Finland
Ablation or modification of the AV-node
4.7
18.4
62
132
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
12.8
18.3
32
25
H3600, E103
ICD-10 Finland
NA
3.0
18.3
108
368
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
18.2
1335
10385
I48.1
ICD-10 Finland
Persistent atrial fibrillation
2.2
18.2
184
842
H50.8
ICD-10 Finland
Other specified strabismus
10.3
18.1
35
34
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
18.1
1696
13655
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.3
18.0
170
754
SPAT1263
SPAT
Sampling
1.2
18.0
3636
31968
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
17.9
452
2842
J01CA04
ATC
amoxicillin; systemic
1.2
17.7
7468
70454
AR6
HP
Catheter ablation of arrhythmia, target: atrial fibrillation
5.0
17.6
56
112
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
17.5
1355
10615
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.8
17.5
319
1827
R03BB04
ATC
tiotropium bromide; inhalant
1.5
17.2
639
4401
K90.0
ICD-10 Finland
Coeliac disease
1.9
17.2
241
1264
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
17.1
1922
15824
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
16.9
400
2474
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
16.9
1402
11091
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
4.8
16.7
55
115
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.4
16.5
145
619
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
16.4
560
3784
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.5
16.4
500
3294
Z71.8
ICD-10 Finland
Other specified counselling
1.3
16.4
1916
15834
N02AX02
ATC
tramadol; systemic, rectal
1.2
16.3
3400
29892
C01BD07
ATC
dronedarone; oral
3.9
16.3
66
169
GB1AA
NOMESCO Finland
Tracheal X-ray examination
12.1
16.3
29
24
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
16.3
4730
42897
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
16.2
1013
7677
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
16.2
533
3575
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
16.0
1157
8966
24400
ICD-8 Finland
Myxoedema, (hypothyreosis) post therapiam
13.5
15.9
27
20
R50.9
ICD-10 Finland
Fever, unspecified
1.4
15.8
998
7576
Z01.7
ICD-10 Finland
Laboratory examination
1.4
15.8
856
6338
XF402
NOMESCO Finland
ECG with work load test
1.4
15.7
768
5581
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
15.7
2002
16712
A02BC01
ATC
omeprazole; systemic
1.2
15.4
2247
19035
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
15.3
923
6952
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
3.8
15.3
64
169
A02BC05
ATC
esomeprazole; systemic
1.2
15.3
3436
30381
2429X
ICD-9 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre or other cause
13.9
15.0
25
18
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
4.5
14.9
52
116
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
4.2
14.8
56
135
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.5
14.7
112
446
R11
ICD-10 Finland
Nausea and vomiting
1.4
14.7
619
4372
SPAT1097
SPAT
Recording of ECG
1.3
14.6
1086
8445
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
14.6
1820
15135
R63.4
ICD-10 Finland
Abnormal weight loss
1.8
14.4
238
1322
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
14.4
3815
34186
J01FA10
ATC
azithromycin; systemic
1.2
14.3
5177
47619
AQ2
HP
Electrophysiological electroanatomical examination
4.2
14.3
53
126
107
Kela drug reimbursment
Pernicious anaemia
2.2
14.2
147
683
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
2.3
14.2
130
570
AQ1
HP
Conventional electrophysiological examination
2.7
14.2
94
347
N05BA04
ATC
oxazepam; oral
1.2
14.1
2069
17512
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.1
14.0
155
742
L28
ICPC
Limited function/disability (L)
1.3
14.0
1141
8990
E20.8
ICD-10 Finland
Other hypoparathyroidism
10.9
14.0
26
24
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
13.9
4297
38971
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
13.9
956
7348
CEC00
NOMESCO Finland
Recession of extraocular muscle
4.2
13.8
51
121
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
53.4
13.8
16
*
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
53.4
13.8
16
*
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
20.0
13.7
20
10
R60.0
ICD-10 Finland
Localized oedema
1.4
13.6
785
5870
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
13.5
1267
10167
2441A
ICD-9 Finland
Acquired hypothyroidism, Other postablative hypothyroidism
34.0
13.5
17
5
R13
ICD-10 Finland
Dysphagia
1.5
13.4
444
2986
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
3.4
13.3
64
191
R02
ICPC
Shortness of breath/dyspnoea
1.3
13.1
876
6707
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
13.1
1528
12599
R4110
NOMESCO Finland
Physiotherapy
1.2
13.1
2043
17389
N05CF01
ATC
zopiclone; oral
1.2
13.0
2603
22692
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.1
12.8
141
673
WX002
NOMESCO Finland
Sedation and analgesia
1.3
12.8
1492
12294
CA1BD
NOMESCO Finland
Extensive orbita CT
11.5
12.8
23
20
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.2
12.5
2642
23122
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
1.8
12.5
206
1147
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
17.3
12.5
19
11
GD1LA
NOMESCO Finland
GD
2.5
12.5
97
392
I49.5
ICD-10 Finland
Sick sinus syndrome
1.7
12.3
243
1432
A10AE06
ATC
insulin degludec; parenteral
1.8
12.3
196
1080
A29
ICPC
General symptom/complaint other
1.3
12.3
786
5976
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
12.2
545
3895
E07.89
ICD-10 Finland
Other specified disorders of thyroid
8.9
12.2
25
28
C08CA01
ATC
amlodipine; oral
1.2
12.2
2566
22450
B81
ICPC
Anaemia vit B12/folate deficiency
1.7
12.1
251
1498
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
12.1
2303
19956
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
12.0
524
3726
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
12.0
1072
8542
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
3.3
12.0
59
180
K02.1
ICD-10 Finland
Caries of dentine
1.2
12.0
4762
43868
2AB04
NOMESCO Finland
NA
5.3
11.9
35
66
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
11.9
327
2107
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
11.9
397
2676
AN1
HP
Coronary angiography
1.4
11.9
690
5167
R51.80
ICD-10 Finland
Headache
1.3
11.8
1138
9154
H3601, E103
ICD-10 Finland
NA
2.7
11.8
79
295
ARB
HP
Catheter ablation of arrhythmia: Cutiing or modification of the AV node
11.7
11.8
21
18
A12AA04
ATC
calcium carbonate; oral
2.3
11.7
107
472
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
11.6
1814
15414
E83.50
ICD-10 Finland
Hypercalcemia
2.3
11.6
101
435
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
11.6
2945
26168
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
11.6
1248
10183
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.4
11.5
588
4308
C09DX04
ATC
valsartan and sacubitril; oral
3.4
11.4
54
160
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
11.4
2298
20002
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.4
11.4
605
4463
SPAT1301
SPAT
No procedures
1.2
11.3
2513
22062
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
9.6
11.2
22
23
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
11.2
4026
36739
R01AD08
ATC
fluticasone; nasal
1.2
11.1
2326
20303
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.5
11.1
385
2619
R42
ICD-10 Finland
Dizziness and giddiness
1.2
11.1
1662
14062
UJF32
NOMESCO Finland
Coloscopy
1.2
11.1
1936
16628
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
11.0
1222
10000
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
10.9
1814
15505
1CX08
NOMESCO Finland
NA
4.4
10.8
38
87
R21
ICPC
Throat symptom/complaint
1.2
10.8
1514
12716
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.2
10.8
1275
10512
7AX01
NOMESCO Finland
NA
17.8
10.7
16
9
A12BA01
ATC
potassium chloride; oral
1.6
10.7
300
1943
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
3.8
10.7
44
117
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
10.7
1432
11966
K29.4
ICD-10 Finland
Chronic atrophic gastritis
1.9
10.7
153
814
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
2.4
10.6
86
358
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
10.6
3593
32592
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
3.1
10.6
56
181
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
10.6
3273
29491
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
10.5
402
2791
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.4
10.5
497
3593
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.3
10.5
97
433
I50
ICD-10 Finland
Heart failure
1.8
10.5
188
1081
N03AX12
ATC
gabapentin; oral
1.3
10.4
1147
9378
24599
ICD-8 Finland
Thyroiditis, Unspecified
+∞
10.4
10
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
10.4
767
5957
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.7
10.3
70
265
2440A
ICD-9 Finland
Acquired hypothyroidism, Postsurgical hypothyroidism
12.0
10.3
18
15
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.2
10.3
1443
12112
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
10.3
1801
15453
H57.1
ICD-10 Finland
Ocular pain
1.6
10.2
228
1396
SPAT1255
SPAT
Intravenous administration of medicine
1.4
10.2
437
3105
A60
ICPC
General and Unspecified, Result test/procedure
1.5
10.1
306
2020
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
10.1
1538
13020
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.8
10.1
164
914
AR5
HP
Catheter ablation of arrhythmia, target: atrial flutter
4.7
10.1
33
71
M03BX02
ATC
tizanidine; oral
1.1
10.0
5425
50815
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
2.1
10.0
113
549
J01FA06
ATC
roxithromycin; oral
1.2
10.0
3388
30703
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
4.9
10.0
31
63
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
10.0
657
5016
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
3.3
10.0
49
151
J01FF01
ATC
clindamycin; systemic
1.2
10.0
2090
18228
R03BA02
ATC
budesonide; inhalant
1.2
9.9
1356
11350
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.4
9.9
499
3650
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.3
9.9
592
4455
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
2.6
9.9
67
254
E04.8
ICD-10 Finland
Other specified nontoxic goitre
3.6
9.8
43
121
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
9.8
1996
17360
C08DA01
ATC
verapamil; systemic
1.6
9.8
276
1793
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
4.6
9.8
32
69
FPG40
NOMESCO Finland
Replacement of pulse generator in transvenous cardioverter-defibrillator
7.0
9.8
23
33
C08DB01
ATC
diltiazem; oral
1.5
9.7
333
2263
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
9.7
6163
58310
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
2.7
9.6
62
229
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
2.0
9.6
119
600
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.7
9.6
176
1019
BA1AE
SPAT
NA
2.7
9.6
63
236
SGA01
NOMESCO Finland
Tooth opening as first aid
1.2
9.6
1132
9331
N02AA05
ATC
oxycodone; systemic
1.3
9.5
950
7672
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
6.3
9.5
24
38
C07AB03
ATC
atenolol; systemic
1.4
9.4
384
2701
2504
FHL
Unilateral resection or enucleation
2.5
9.4
69
274
R49.08
ICD-10 Finland
Other specified dysphonia
1.8
9.4
162
920
E89
ICD-10 Finland
Postprocedural endocrine and metabolic disorders, not elsewhere classified
100.1
9.4
10
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
9.4
890
7143
J01FA09
ATC
clarithromycin; systemic
1.2
9.4
2585
23042
N03AX16
ATC
pregabalin; oral
1.2
9.3
1801
15582
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
2.9
9.3
54
186
R05
ICPC
Cough
1.2
9.3
1717
14793
WF099
NOMESCO Finland
Other radiotherapy
3.1
9.3
49
160
CEW99
NOMESCO Finland
Other operation on extraocular muscle
6.4
9.2
23
36
A98
ICPC
Health maint/preventive medicine
1.3
9.2
9384
91959
ZXA05
NOMESCO Finland
Left side
1.2
9.2
1896
16502
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
9.2
614
4702
H50.0
ICD-10 Finland
Convergent concomitant strabismus
2.9
9.2
54
189
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
2.2
9.1
87
393
D01
ICPC
Abdominal pain/cramps general
1.3
9.1
768
6074
R06AE07
ATC
cetirizine; oral
1.1
9.1
3772
34608
ZXA00
NOMESCO Finland
Right side
1.2
9.1
2021
17697
WZC30
NOMESCO Finland
Teaching
1.3
9.1
908
7338
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
9.0
1062
8746
M14.5*E03.9
ICD-10 Finland
Arthropathy in hypothyroidism (E00-E03+)
4.4
9.0
31
71
H02AB04
ATC
methylprednisolone; systemic
1.2
9.0
1098
9081
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
8.9
1344
11357
A08
ICPC
Swelling
1.5
8.9
283
1893
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
7.4
8.9
20
27
-60
ICPC
Result test/procedure
1.4
8.9
425
3085
G47.3
ICD-10 Finland
Sleep apnoea
1.2
8.9
1338
11305
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
2.8
8.9
54
194
N07BA03
ATC
varenicline; oral
1.5
8.8
327
2264
B01AF01
ATC
rivaroxaban; oral
1.3
8.8
763
6061
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.2
8.8
87
401
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.7
8.7
185
1119
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.2
8.7
1063
8790
F29
ICPC
Eye symptom/complaint other
1.3
8.6
563
4297
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
8.6
875
7084
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
8.6
610
4709
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
2.3
8.6
73
315
M79.6
ICD-10 Finland
Pain in limb
1.1
8.6
2883
26043
J01MA12
ATC
levofloxacin; systemic
1.2
8.6
1257
10593
R01AD09
ATC
mometasone; nasal
1.1
8.6
3821
35188
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
8.4
2277
20235
W84
ICPC
Pregnancy high risk
1.6
8.4
196
1215
G04BE03
ATC
sildenafil; oral
2.5
8.4
65
265
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.3
8.4
492
3692
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.5
8.4
239
1560
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
5.6
8.4
23
41
A02BA02
ATC
ranitidine; systemic
1.2
8.4
1453
12437
L15
ICPC
Knee symptom/complaint
1.2
8.4
1572
13556
24509
ICD-8 Finland
Thyroiditis, Unspecified
+∞
8.3
8
*
O992, E050
ICD-10 Finland
NA
+∞
8.3
8
*
R07.3
ICD-10 Finland
Other chest pain
1.3
8.3
624
4860
R25.1
ICD-10 Finland
Tremor, unspecified
1.6
8.3
180
1099
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.3
8.3
73
320
SPAT1254
SPAT
Administration of medicine
1.2
8.3
1009
8343
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
8.2
5973
56664
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
2.0
8.2
95
468
K05
ICPC
Irregular heartbeat other
1.6
8.2
192
1195
M54.5
ICD-10 Finland
Low back pain
1.1
8.2
2627
23640
-50
ICPC
Medication/prescr/renewal
1.5
8.2
284
1938
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
4.2
8.2
29
69
SPAT1312
SPAT
General health counselling
1.2
8.1
2530
22709
205
Kela drug reimbursment
Chronic hypertension
1.2
8.1
1857
16281
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
1.6
8.1
183
1127
FPE96
NOMESCO Finland
Other implantation or replacement of transvenous cardiac pacemaker
3.5
8.1
36
104
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.5
8.1
295
2036
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.3
8.1
648
5095
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.1
8.0
3274
29935
G44.2
ICD-10 Finland
Tension-type headache
1.2
8.0
1028
8541
A99
ICPC
Disease/condition unspecnature/site
1.3
8.0
540
4141
M01AE03
ATC
ketoprofen; systemic, rectal
1.1
8.0
2966
26943
FM1CD
NOMESCO Finland
Very extensive CT of heart
4.0
8.0
30
75
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
8.9
8.0
16
18
E06
ICD-10 Finland
Thyroiditis
10.0
8.0
15
15
TFP52
NOMESCO Finland
Ablation treatment of ventricular tachycardia due to structural heart defect
10.0
8.0
15
15
A09
ICPC
Sweating problem
2.2
8.0
79
366
C09CA01
ATC
losartan; oral
1.2
7.9
1679
14625
R60.9
ICD-10 Finland
Oedema, unspecified
1.4
7.9
311
2178
A27
ICPC
Fear of other disease NOS
1.5
7.9
285
1965
E06.5
ICD-10 Finland
Other chronic thyroiditis
13.0
7.9
13
10
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.2
7.9
1282
10913
CE2W4
NOMESCO Finland
Eye movement mapping
5.1
7.8
23
45
A91
ICPC
Abnormal result investigation NOS
1.5
7.8
268
1826
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.3
7.8
561
4344
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
1.8
7.8
117
638
A10AB06
ATC
insulin glulisine; parenteral
2.3
7.8
65
280
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.4
7.7
418
3100
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.1
7.7
2464
22153
B01AB04
ATC
dalteparin; parenteral
1.4
7.7
317
2243
L17
ICPC
Foot/toe symptom/complaint
1.2
7.7
1891
16670
WX290
NOMESCO Finland
Other blockade of nerve
1.1
7.7
3494
32155
M25.5
ICD-10 Finland
Pain in joint
1.2
7.6
2284
20434
TKC20
NOMESCO Finland
Catheterisation of bladder
1.4
7.6
409
3030
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
1.8
7.6
116
638
J02AC01
ATC
fluconazole; systemic
1.1
7.6
3738
34563
SPAT1260
SPAT
Consultation of another employee
1.2
7.6
1324
11337
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.3
7.6
542
4197
D06
ICPC
Abdominal pain localized other
1.3
7.5
562
4374
R01AD12
ATC
fluticasone furoate; nasal
1.1
7.5
2364
21219
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
2.0
7.5
84
412
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.3
7.5
545
4228
L03
ICPC
Low back symptom/complaint
1.2
7.5
1868
16485
C09AA02
ATC
enalapril; systemic
1.2
7.5
1289
11030
WX320
NOMESCO Finland
Spinalanesthesy
1.2
7.5
1692
14820
WX902
NOMESCO Finland
External defibrillation of heart
3.8
7.4
29
76
BA1MN
NOMESCO Finland
Thyroid gland isotope imaging with calculation
80.1
7.4
8
*
C03AA03
ATC
hydrochlorothiazide; oral
1.3
7.4
654
5208
R07.0
ICD-10 Finland
Pain in throat
1.4
7.4
412
3071
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
1.7
7.4
134
777
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
5.3
7.4
21
40
MAA00
NOMESCO Finland
Amniocentesis
1.7
7.4
148
884
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
4.5
7.4
24
53
A02BC03
ATC
lansoprazole; oral
1.1
7.3
2270
20348
E04
ICD-10 Finland
Other nontoxic goitre
3.3
7.3
34
103
SPAT1216
SPAT
Assessment of functional ability
1.2
7.3
1042
8756
2451A
ICD-9 Finland
Thyroiditis, Subacute thyroiditis
+∞
7.3
7
*
3762A
ICD-9 Finland
Disorders of the orbit, Endocrine exophthalmos
+∞
7.3
7
*
E50.9
ICD-10 Finland
Vitamin A deficiency, unspecified
10.8
7.3
13
12
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
1.6
7.3
164
1012
-34
ICPC
Blood test
1.6
7.3
198
1285
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.1
7.2
4375
40919
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.3
7.2
425
3198
SPAT1283
SPAT
Restricted health certificate
1.2
7.2
1289
11059
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.5
7.2
237
1604
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.7
7.2
138
815
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
3.3
7.2
33
99
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.6
7.2
170
1065
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.4
7.2
304
2161
FPJ21
NOMESCO Finland
Revision of cardioverter-defibrillator with ventricular electrode
7.3
7.2
16
22
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.1
7.2
4763
44785
N06AX11
ATC
mirtazapine; oral
1.1
7.1
2517
22761
T90
ICPC
Diabetes non-insulin dependent
1.2
7.1
1464
12715
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
7.1
1501
13069
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
7.1
586
4630
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.2
7.1
962
8046
R03BA05
ATC
fluticasone; inhalant
1.2
7.1
1371
11850
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.4
7.0
267
1862
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
2.6
7.0
49
190
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.5
7.0
203
1336
A12AA06
ATC
calcium lactate gluconate; oral
4.7
7.0
22
47
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.2
7.0
974
8165
UKC02
NOMESCO Finland
Cystoscopy
1.2
6.9
917
7646
ZX108
NOMESCO Finland
Inhalation
2.5
6.9
49
193
A03
ICPC
Fever
1.2
6.9
1096
9305
XF602
NOMESCO Finland
Bloodpressure monitoring
2.1
6.9
69
323
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
7.5
6.9
15
20
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
4.6
6.9
22
48
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
1.5
6.9
221
1490
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.4
6.9
297
2122
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.2
6.9
1265
10885
UJF30
NOMESCO Finland
Ileoscopy through colon
1.3
6.8
643
5161
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
2.0
6.8
76
373
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
6.8
612
4884
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.3
6.8
581
4606
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
2.7
6.8
44
164
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.3
6.8
514
4014
TFP45
NOMESCO Finland
Ablation treatment of non-typical atrial flutter
6.1
6.8
17
28
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
6.7
301
2166
L14
ICPC
Leg/thigh symptom/complaint
1.3
6.7
479
3705
P01AB01
ATC
metronidazole; oral, rectal
1.1
6.6
3358
31032
I41.8*D86.8
ICD-10 Finland
Sarcoid myocarditis
3.7
6.6
27
74
N17
ICPC
Vertigo/dizziness
1.2
6.6
761
6252
R52.9
ICD-10 Finland
Pain, unspecified
1.3
6.6
575
4572
A28
ICPC
Limited function/disability NOS
1.2
6.6
935
7850
N05CF02
ATC
zolpidem; oral
1.2
6.6
1344
11657
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.3
6.6
385
2895
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
2.0
6.6
76
378
105
Kela drug reimbursment
Adrenal cortical hypofunction
3.5
6.6
28
80
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
6.6
367
2740
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.5
6.6
193
1276
K77
ICPC
Heart failure
1.8
6.5
107
605
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.4
6.5
287
2058
E21.2
ICD-10 Finland
Other hyperparathyroidism
2.9
6.5
36
124
RD210
NOMESCO Finland
NA
1.8
6.5
112
641
H3603, E103
ICD-10 Finland
NA
2.2
6.5
64
298
S06.0
ICD-10 Finland
Concussion
1.2
6.5
675
5483
C10AA05
ATC
atorvastatin; oral
1.1
6.5
2581
23504
M79.1
ICD-10 Finland
Myalgia
1.2
6.5
921
7734
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.2
6.5
840
6992
J45.1
ICD-10 Finland
Nonallergic asthma
1.3
6.5
455
3518
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.2
6.5
931
7833
AS8
HP
Physiological arrhythmia pacemaker insertionDDD (R) S
5.3
6.4
18
34
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.3
6.4
504
3954
SPAT1229
SPAT
Assessment of need for aid
1.3
6.4
514
4044
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.3
6.4
565
4500
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.5
6.4
205
1378
6481A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Thyroid dysfunction[HYPERTHYREOSIS IN GRAVIDITATE]
14.3
6.4
10
7
XF640
NOMESCO Finland
NA
1.6
6.4
166
1066
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.3
6.4
363
2723
N30.0
ICD-10 Finland
Acute cystitis
1.2
6.4
1089
9309
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
3.1
6.3
31
99
3AC01
NOMESCO Finland
NA
2.0
6.3
70
345
SPAT1310
SPAT
Counselling related to known health issue
1.1
6.3
2472
22484
I48.4
ICD-10 Finland
Atypical atrial flutter
3.4
6.3
28
83
TBA20
NOMESCO Finland
Aspiration cytology of thyroid gland
5.5
6.3
17
31
M01AB55
ATC
diclofenac, combinations; oral
1.3
6.3
476
3721
C08CA02
ATC
felodipine; oral
1.3
6.3
568
4540
J01MA02
ATC
ciprofloxacin; systemic
1.1
6.3
2908
26720
A13
ICPC
Concern/fear medical treatment
1.8
6.3
106
606
CKC12
NOMESCO Finland
Photocoagulation of retina
1.4
6.3
251
1772
TK810
NOMESCO Finland
Hemofiltration
2.9
6.3
36
125
2452A
ICD-9 Finland
Thyroiditis, Chronic lymphocytic thyroiditis
+∞
6.2
6
*
E8901, E050
ICD-10 Finland
NA
+∞
6.2
6
*
I43.8*E05.9
ICD-10 Finland
Thyrotoxic heart disease
+∞
6.2
6
*
R05FB02
ATC
cough suppressants and expectorants
1.1
6.2
3041
28021
I25.2
ICD-10 Finland
Old myocardial infarction
1.4
6.2
304
2225
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.4
6.2
268
1921
Z01.2
ICD-10 Finland
Dental examination
1.1
6.2
3289
30463
WZA90
NOMESCO Finland
Other doctors statement
1.2
6.2
1682
14927
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
6.1
273
1962
WX872
NOMESCO Finland
Intensive care
1.4
6.1
255
1812
R05FA02
ATC
opium derivatives and expectorants; systemic
1.1
6.1
3310
30669
L95
ICPC
Osteoporosis
1.5
6.1
215
1479
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
2.3
6.1
53
232
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
1.7
6.1
112
655
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
3.1
6.1
30
96
M02AA07
ATC
piroxicam; topical
1.1
6.1
2925
26917
L12
ICPC
Hand/finger symptom/complaint
1.2
6.1
979
8320
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.1
6.1
3136
28977
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.4
6.1
278
2011
D09
ICPC
Nausea
1.4
6.1
268
1923
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.2
6.1
839
7025
3A149
NOMESCO Finland
NA
12.5
6.1
10
8
I49.1
ICD-10 Finland
Atrial premature depolarization
1.5
6.1
211
1446
P06
ICPC
Sleep disturbance
1.2
6.0
639
5201
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.4
6.0
251
1786
M04AA01
ATC
allopurinol; systemic
1.2
6.0
665
5439
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.4
6.0
300
2200
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6763
46562
2.11
316.34
7.6
6.2
mmol/l
1.2
1.2
0.79
5698
39105
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
10599
76640
6.56
307.65
12.9
3.9
pmol/l
15.6
14.7
248.93
10201
70051
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
4987
1375
63.77
307.65
2.6
1.2
iu/l
21.8
12.0
0.34
2566
328
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10747
89256
4.65
307.65
14.2
4.7
mu/l
1.7
2.0
9.44
10318
82216
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
3051
6834
5.73
307.65
1.4
1.2
iu/ml
198.2
143.0
6.97
1416
2557
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5907
5357
21.84
307.65
6.7
2.4
pmol/l
4.7
4.4
60.18
5489
4700
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
6152
42071
2.01
278.51
6.7
5.5
mmol/l
1.2
1.2
0.01
5676
37933
(3013650) Neutrophils [#/volume] in Blood by Automated count
7425
54713
2.03
266.28
9.5
8.9
e9/l
3.9
4.0
4.97
6476
47753
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1691
7017
2.66
263.65
3.4
3.5
ng/l
68.1
86.5
15.92
1488
5978
(3018418) pH of Serum or Plasma
4430
27887
1.96
245.44
4.8
3.8
ph
7.4
7.4
0.10
852
5302
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
274
307
9.12
222.87
1.7
1.4
pmol/l
17.5
14.4
3.76
242
251
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
8853
72753
1.98
191.62
8.7
7.3
u/l
78.5
77.5
1.55
8449
68338
(3015377) Calcium [Moles/volume] in Serum or Plasma
4659
32462
1.74
167.37
3.2
3.3
mmol/l
2.3
2.4
12.02
4119
28239
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5553
41552
1.66
145.78
2.6
2.3
nmol/l
76.7
2266.8
0.50
5034
37464
(3013707) Erythrocyte sedimentation rate by Westergren method
8506
71360
1.76
142.30
4.4
4.1
mm/h
12.2
12.2
0.05
7963
66178
(40758558) Short blood count panel - Blood
3516
24043
1.67
126.22
7.3
6.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
355
919
3.96
120.17
3.9
4.9
u/ml
146.8
91.7
0.84
113
272
(3013115) Eosinophils [#/volume] in Blood
6174
48928
1.57
116.89
6.2
6.0
e9/l
0.2
0.2
0.17
5458
42941
(3022096) Basophils/100 leukocytes in Blood
5526
42730
1.57
116.31
6.1
6.0
%
0.7
0.7
3.05
5134
39719
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
627
2401
2.71
111.15
1.2
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
5668
44383
1.55
110.64
6.3
6.2
%
8.6
8.4
2.82
5281
41477
(3002030) Lymphocytes/100 leukocytes in Blood
5798
45654
1.55
110.20
6.1
6.0
%
28.1
28.4
1.69
5386
42449
(3006504) Eosinophils/100 leukocytes in Blood
5641
44149
1.55
110.20
6.1
5.9
%
2.8
2.8
0.07
5245
41000
(3006315) Basophils [#/volume] in Blood
5964
47318
1.55
109.06
5.9
5.8
e9/l
0.0
0.0
4.91
5169
40855
(3019198) Lymphocytes [#/volume] in Blood
6086
48541
1.55
108.36
5.9
5.8
e9/l
1.9
1.9
1.82
5383
42714
(3001604) Monocytes [#/volume] in Blood
5934
47106
1.54
107.66
5.9
5.8
e9/l
0.6
0.6
0.13
5156
40697
(3018010) Neutrophils/100 leukocytes in Blood
5698
45039
1.53
103.94
5.9
5.8
%
57.1
57.0
0.30
5310
42025
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1554
8841
1.88
103.50
2.2
2.1
nmol/l
375.0
376.3
0.10
1423
8065
(3019550) Sodium [Moles/volume] in Serum or Plasma
10520
96930
2.13
98.73
19.5
15.0
mmol/l
139.7
139.7
0.21
10324
94400
(3023103) Potassium [Moles/volume] in Serum or Plasma
10537
97191
2.13
97.86
19.8
15.1
mmol/l
3.9
3.9
1.28
10315
94466
(42870588) Differential panel, method unspecified - Blood
4250
31889
1.53
96.42
5.7
5.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
1055
5488
2.02
90.94
2.4
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
7586
64841
1.51
87.66
4.4
3.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
5229
41693
1.47
84.42
11.0
9.2
e9/l
0.0
0.0
0.15
4326
34025
(3013826) Glucose [Moles/volume] in Serum or Plasma
6490
53974
1.47
84.21
5.1
4.4
mmol/l
6.7
6.6
1.59
6104
50092
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
3110
22348
1.54
83.29
1.4
1.3
u/ml
1.7
1.6
0.12
813
6108
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
236
604
3.97
81.13
5.0
6.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1765
11229
1.68
78.12
5.5
5.3
mmol/l
1.0
1.0
0.77
1617
10425
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3351
24753
1.50
77.68
4.0
2.9
ng/l
1389.9
1288.9
0.81
2894
21093
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2167
14632
1.59
75.20
3.7
3.2
mmol/l
0.8
0.8
4.25
2009
13579
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5357
43532
1.44
74.71
3.3
2.8
ug/l
104.2
107.6
0.61
4970
40421
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
10276
95384
1.80
72.85
16.8
13.4
mg/l
20.8
22.1
3.81
8440
75134
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
9723
88944
1.64
72.54
15.9
12.4
ml/min/173m2
82.0
81.9
0.30
8341
73101
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
10711
100796
2.06
72.16
13.3
10.1
u/l
24.3
25.0
4.47
10464
97168
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
9388
85603
1.55
66.14
6.3
5.4
mmol/mol
40.0
39.2
11.60
8716
79181
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5826
48763
1.40
64.87
6.2
5.9
umol/l
10.9
10.7
0.65
5523
46062
(3007164) IgA [Mass/volume] in Serum or Plasma
2620
19053
1.49
63.12
1.5
1.4
g/l
2.2
2.3
2.45
1517
11457
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1922
13098
1.56
62.78
2.6
2.4
g/l
2.4
2.4
1.31
1758
12073
(3024561) Albumin [Mass/volume] in Serum or Plasma
4935
40330
1.39
62.38
4.7
4.5
g/l
35.5
35.7
1.79
4563
37330
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3128
23608
1.45
62.02
2.5
2.2
mg/l
3.0
2.9
0.19
2707
20174
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
4720
38336
1.40
61.64
2.1
1.9
pmol/l
96.2
97.7
1.28
2476
19236
(3022948) Iron [Moles/volume] in Serum or Plasma
2060
14317
1.54
61.43
2.6
2.4
umol/l
13.2
13.1
0.19
1892
13210
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4256
34084
1.40
59.89
4.1
3.4
ng/l
57.5
67.0
0.16
2746
21901
(3032080) INR in Blood by Coagulation assay
4409
35640
1.39
58.16
12.0
8.0
inr
1.3
1.2
3.45
1348
10353
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
423
1830
2.36
57.58
2.2
2.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1775
12146
1.55
56.31
2.7
2.5
%
21.9
22.3
0.72
1516
10363
(3044640) Blood type and Crossmatch panel - Blood
3826
30422
1.39
54.84
2.4
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
9828
91400
1.55
54.22
4.8
4.4
mmol/l
5.9
5.8
7.79
8998
83550
(3027456) Digoxin [Moles/volume] in Serum or Plasma
373
1601
2.37
51.68
3.4
3.2
nmol/l
0.8
0.8
0.25
298
1223
(40761511) CBC panel - Blood by Automated count
10474
99294
1.69
48.74
17.4
12.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1192
7759
1.60
46.38
3.9
3.6
mmol/l
1.2
1.2
3.79
1053
6723
(3002385) Erythrocyte distribution width [Ratio]
8654
79389
1.38
43.67
22.6
16.2
%
13.7
13.7
0.56
8512
77699
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2298
17304
1.41
43.48
4.4
3.5
ng/l
264.4
407.8
0.86
1760
12752
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2911
22927
1.36
41.65
2.3
2.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2736
21354
1.37
41.42
2.5
1.7
mg/l
1.1
1.1
0.27
2063
16256
(3026782) Osmolality of Urine
2334
17791
1.39
40.74
3.0
2.7
mosm/kgh2o
521.6
528.3
0.79
1980
15044
(3022217) INR in Platelet poor plasma by Coagulation assay
1584
11263
1.47
40.59
29.9
22.8
inr
1.4
1.3
1.28
211
1626
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3613
29520
1.33
40.10
2.6
2.5
u/l
57.3
57.7
0.15
3320
27129
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3399
27540
1.33
39.94
2.2
2.1
u/l
190.7
192.1
0.02
3205
25748
(3033658) Prothrombin time (PT) actual/Normal
2953
23556
1.34
38.23
4.4
3.7
%
89.7
93.0
9.68
2884
22905
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1906
14199
1.41
37.69
1.9
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2276
17499
1.38
37.23
2.9
2.9
mmol/l
2.4
2.5
1.86
1934
15274
(3013512) EKG study
3254
26454
1.32
36.64
4.4
3.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5212
45147
1.28
36.22
4.0
3.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1121
7591
1.53
36.18
4.0
3.8
kpa
5.9
5.8
0.71
1077
7361
(3002032) Base excess in Venous blood by calculation
1118
7573
1.53
36.03
4.0
3.8
mmol/l
2.0
2.0
0.06
921
6204
(3012544) pH of Venous blood
1148
7860
1.51
35.13
4.0
3.8
ph
7.4
7.4
—
5
38
(3007461) Platelets [#/volume] in Blood
10918
105659
1.82
34.57
27.9
19.8
e9/l
258.4
258.3
0.05
10752
102964
(3037467) Urinalysis macro (dipstick) panel - Urine
7327
66464
1.29
34.33
4.9
4.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
10920
105711
1.81
34.15
27.7
19.7
pg
30.1
30.2
14.29
10831
104221
(3026361) Erythrocytes [#/volume] in Blood
10920
105725
1.81
33.94
27.8
19.8
e12/l
4.5
4.4
19.87
10711
102763
(3024731) MCV [Entitic volume]
10919
105716
1.81
33.88
27.8
19.8
fl
90.7
90.9
7.98
10831
104229
(3000963) Hemoglobin [Mass/volume] in Blood
10921
105751
1.81
33.73
28.0
19.9
g/l
134.1
133.5
5.09
10831
104281
(3010813) Leukocytes [#/volume] in Blood
10920
105748
1.80
33.58
27.9
19.9
e9/l
6.6
6.7
0.49
10716
102751
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1067
7260
1.52
33.57
3.9
2.8
ng/l
258.4
182.2
2.78
971
6593
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
6951
62827
1.27
32.52
3.3
3.0
u/l
43.8
44.4
0.26
6535
58595
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3674
30774
1.29
32.07
3.2
3.1
u/l
29.6
33.8
4.12
3491
29151
(3019225) pH of Specimen
1312
9394
1.45
31.88
5.1
4.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
9960
94693
1.41
31.53
5.2
4.7
mmol/l
2.8
2.8
9.88
9197
87258
(3035637) Corticotropin [Mass/volume] in Plasma
248
1113
2.26
31.07
1.7
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
1144
8017
1.47
31.04
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
1010
6912
1.51
30.81
8.8
7.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3086
25378
1.30
30.78
3.5
3.0
e6/l
0.4
0.4
0.21
2325
18882
(3002582) Erythrocytes [#/volume] in Urine
3324
27603
1.29
30.74
3.6
3.1
e6/l
99.9
78.4
0.29
2548
20861
(3023368) Bacteria identified in Blood by Culture
2874
23419
1.30
30.71
4.5
4.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
2635
21275
1.31
30.01
4.1
4.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
3200
26543
1.29
29.62
4.3
3.9
mg/mmol
9.2
9.0
0.06
1963
16019
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
631
3918
1.65
29.37
4.1
4.1
mmol/l
24.3
24.3
0.10
590
3511
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
9790
93018
1.38
29.23
4.7
4.3
mmol/l
4.7
4.8
23.67
9090
86172
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1327
9666
1.42
29.20
5.0
4.0
u/l
236.5
242.9
0.95
1254
9090
(3020779) Urea [Moles/volume] in Serum or Plasma
1033
7191
1.48
28.90
9.7
6.9
mmol/l
9.9
9.4
1.54
982
6841
(3009508) Creatinine [Moles/volume] in Urine
3273
27297
1.28
28.84
3.4
3.1
mmol/l
7.0
7.1
0.53
2703
22946
(3027945) Reticulocytes/100 erythrocytes in Blood
1310
9541
1.42
28.82
2.5
2.4
%
1.8
1.8
1.04
1165
8403
(3012516) Albumin [Mass/volume] in Urine
3053
25258
1.29
28.64
3.5
3.2
mg/l
517.1
426.9
0.42
1939
15105
(3020630) Protein [Mass/volume] in Serum or Plasma
1021
7123
1.48
28.23
2.3
2.5
g/l
65.5
66.5
4.42
927
6436
(36304419) Bacteria [Presence] in Urine
3009
24902
1.28
28.04
3.4
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1783
13734
1.35
27.87
1.4
1.4
titre
516.5
553.4
0.37
410
2983
(3031040) Bacteria [#/volume] in Urine by Automated count
7055
64400
1.25
27.87
5.2
4.5
e6/l
1235.5
2233.1
1.08
97
804
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
9406
89059
1.32
26.90
4.1
3.8
mmol/l
1.3
1.3
0.37
8631
81599
(3018095) Leukocytes [#/volume] in Urine
3865
33117
1.25
26.60
4.2
3.6
e6/l
90.4
107.0
0.88
2740
22716
(3021960) Folate [Moles/volume] in Serum or Plasma
2608
21359
1.29
26.05
1.6
1.5
nmol/l
20.1
21.1
2.71
2269
18189
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
9697
92344
1.34
25.68
4.6
4.2
mmol/l
1.5
1.5
15.90
8945
85184
(3000850) Epithelial cells [#/volume] in Urine
2363
19202
1.29
24.91
2.8
2.5
e6/l
6.9
6.7
0.25
2045
16678
(3019309) Folate [Moles/volume] in Red Blood Cells
2144
17237
1.30
24.47
1.8
1.7
nmol/l
1101.0
1187.7
4.76
1672
12960
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1289
9613
1.38
24.47
1.8
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1820
14330
1.32
24.17
3.2
2.8
e6/l
3.8
3.6
0.35
995
7531
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1405
10663
1.36
23.88
2.6
2.6
umol/l
7.9
7.8
0.11
1206
9094
(3024354) Oxygen [Partial pressure] in Venous blood
892
6259
1.46
23.82
3.5
3.2
kpa
4.6
4.6
0.00
851
6051
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1284
9610
1.38
23.81
1.8
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1011
7301
1.42
23.10
7.6
6.6
mmol/l
1.2
1.3
1.68
972
7043
(3052851) Hemolysis interference index of Serum or Plasma
451
2775
1.65
21.76
3.3
3.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1378
10589
1.34
21.45
7.6
6.6
mmol/l
104.2
104.4
0.36
1351
10362
(40768797) Stomach Pathology biopsy report
1690
13373
1.31
21.41
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
304
1698
1.81
20.77
3.3
3.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4577
40649
1.21
20.75
2.1
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3569
30938
1.22
20.65
3.5
3.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
637
4320
1.50
20.14
9.7
8.7
mmol/l
24.6
24.4
1.18
602
4039
(3009542) Hematocrit [Volume Fraction] of Blood
9146
87081
1.26
19.72
20.4
14.4
%
39.6
39.3
2.07
6697
63557
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
284
1582
1.82
19.60
1.2
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
78
250
3.13
19.33
1.4
1.6
ug/l
0.4
0.4
0.12
38
168
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2168
17932
1.26
19.09
1.3
1.3
iu/ml
28.7
34.4
1.06
653
5710
(3026493) Urate [Moles/volume] in Serum or Plasma
2775
23613
1.23
18.86
2.6
2.4
umol/l
4503.8
4263.0
0.10
2359
20385
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
423
2666
1.61
18.56
4.3
3.2
u/ml
0.4
0.4
0.08
248
1508
(3010838) Calcium [Moles/time] in 24 hour Urine
122
506
2.43
18.50
1.8
1.6
mmol/24h
3.7
5.9
—
10
40
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1201
9273
1.33
17.93
3.5
3.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1653
13351
1.28
17.60
2.8
2.1
s
30.3
29.6
4.33
1603
12933
(3004119) Hemoglobin [Mass/volume] in Venous blood
699
4956
1.44
17.59
3.7
3.3
g/l
131.5
127.8
4.56
678
4836
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
204
1063
1.94
17.38
1.1
1.2
u/l
73.7
61.6
1.00
141
706
(3020961) Endomysium IgA Ab [Titer] in Serum
671
4749
1.44
17.05
1.2
1.1
titre
111.0
208.2
1.25
25
106
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1885
15530
1.26
16.95
3.0
2.6
e6/l
1.2
1.4
0.67
1049
8669
(3003396) Base excess in Arterial blood by calculation
1224
9549
1.32
16.94
7.4
6.8
mmol/l
1.2
1.1
0.26
959
7511
(3000492) Spirometry study
1146
8862
1.33
16.89
1.5
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1224
9561
1.31
16.78
7.5
6.7
kpa
5.1
5.1
0.61
1173
9120
(3027801) Oxygen [Partial pressure] in Arterial blood
1223
9558
1.31
16.70
7.5
6.7
kpa
12.1
12.6
2.92
1170
9111
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
904
6759
1.37
16.66
1.6
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
554
3798
1.48
16.62
1.4
1.6
u/ml
13.4
15.7
—
8
106
(3004588) Protein electrophoresis panel - Serum or Plasma
804
5903
1.39
16.57
2.0
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
718
5174
1.41
16.51
1.7
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
388
2466
1.59
16.48
1.8
2.2
g/l
0.0
0.0
1.06
354
2245
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
430
2803
1.56
16.37
2.0
2.3
g/l
0.5
0.8
2.10
370
2399
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
586
4075
1.46
16.35
1.1
1.1
u/ml
1.5
2.2
0.39
11
65
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
556
3832
1.47
16.24
1.8
1.7
g/l
1.6
1.5
0.13
477
3250
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2034
16979
1.24
16.19
1.3
1.3
u/ml
8.1
12.3
2.40
740
6733
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
453
2998
1.53
16.10
1.6
1.6
titre
280.0
313.6
0.10
23
143
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
378
2404
1.59
16.02
1.3
1.5
iu/ml
7.5
15.6
—
5
66
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
399
2576
1.57
15.85
1.8
2.1
g/l
37.4
37.8
0.90
346
2193
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
363
2295
1.60
15.77
1.8
2.2
g/l
0.0
0.0
0.78
330
2084
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
464
3102
1.52
15.74
1.8
2.3
g/l
3.1
3.1
0.57
362
2396
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1130
8812
1.31
15.64
2.5
2.4
u/l
39.9
42.5
0.16
975
7487
(3023520) Reticulocytes [#/volume] in Blood
933
7081
1.35
15.59
2.4
2.5
e9/l
72.3
70.4
0.77
696
5285
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2868
24871
1.20
15.56
1.7
1.6
mmol/l
1.3
1.4
0.56
2358
20965
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2349
19993
1.22
15.44
1.7
1.6
pmol/l
43859188.9
33271369.3
0.37
1954
16558
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
357
2265
1.59
15.30
1.8
2.2
g/l
0.0
0.0
0.00
330
2078
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
483
3293
1.49
14.92
1.9
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
482
3291
1.49
14.78
1.9
2.2
g/l
3.8
3.8
0.03
357
2331
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
483
3301
1.48
14.74
1.9
2.2
g/l
7.6
7.4
0.60
365
2460
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
240
1395
1.74
14.44
1.2
1.3
nmol/l
0.6
1.7
0.70
229
1339
(3021601) Nitrite [Presence] in Urine by Test strip
5209
47750
1.17
14.35
5.5
5.0
estimate
0.0
0.0
2.57
1072
8967
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
561
3968
1.44
14.32
2.1
2.0
u/l
39.0
39.5
0.24
498
3524
(3035350) Ketones [Presence] in Urine by Test strip
5180
47508
1.17
14.07
4.0
3.7
estimate
0.0
0.0
1.08
1044
8818
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
240
1406
1.72
14.06
1.2
1.3
nmol/l
0.1
0.3
1.95
12
91
(3048689) Calprotectin [Mass/mass] in Stool
1511
12396
1.25
13.88
2.0
2.2
ug/g
124.7
125.9
0.04
1161
9619
(3016502) Oxygen saturation in Arterial blood
1071
8440
1.30
13.66
7.9
7.2
%
95.0
95.8
2.78
1030
8115
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
449
3077
1.48
13.54
1.9
2.2
g/l
9.9
10.2
0.69
378
2565
(3009261) Glucose [Presence] in Urine by Test strip
5239
48189
1.16
13.46
4.1
3.8
estimate
0.0
0.0
0.02
1037
8869
(3042936) Bacteria identified in Isolate by Culture
1525
12575
1.25
13.35
2.2
1.9
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
135
673
2.02
13.18
2.2
2.1
nmol/l
17.7
18.4
0.43
123
628
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
540
3875
1.41
12.74
3.2
2.9
%
1.2
1.2
1.31
534
3852
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
438
3034
1.46
12.53
1.7
1.7
g/l
1.2
1.2
0.00
406
2867
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
428
2953
1.47
12.50
1.7
1.7
g/l
0.2
0.2
0.36
398
2784
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
528
3789
1.41
12.46
2.0
2.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
528
3790
1.41
12.45
3.3
2.8
%
0.6
0.7
1.18
516
3638
(40761536) Microorganisms panel - Urine sediment
1039
8255
1.28
12.41
4.1
4.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
370
2488
1.50
12.28
2.3
2.0
mg/l
11.0
11.0
0.01
346
2304
(3005719) IgG [Mass/volume] in Serum or Plasma
895
6987
1.30
12.23
2.5
2.7
g/l
10.1
10.4
1.72
808
6401
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
217
1288
1.70
12.18
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
291
1862
1.58
12.11
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
291
1862
1.58
12.11
1.3
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6684
62858
1.15
12.07
3.2
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1321
10859
1.24
11.82
2.0
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
911
7174
1.29
11.65
2.5
2.3
ug/l
9.7
6.7
1.93
770
6157
(3003694) ABO and Rh group [Type] in Blood
2977
26436
1.17
11.64
1.5
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
715
5454
1.33
11.53
1.8
1.9
g/l
1.2
1.4
1.61
655
4970
(3041096) Erythrocytes [Presence] in Urine by Automated
2903
25748
1.17
11.50
3.8
3.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
659
4971
1.35
11.46
3.6
3.4
mmol/l
2.0
1.9
0.48
494
3710
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
181
1041
1.75
11.41
2.7
3.3
nmol/l
4.1
10.8
0.68
171
1006
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
414
2893
1.45
11.34
3.0
2.2
ug/l
337.4
585.4
1.70
383
2685
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
112
554
2.03
11.24
1.0
1.1
nmol/l
7.0
7.6
0.04
20
113
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
481
3462
1.41
11.19
1.9
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
982
7850
1.27
11.15
3.8
4.1
%
1.0
0.9
0.31
254
2145
(3025159) Blasts/100 leukocytes in Blood
896
7084
1.29
11.11
3.8
4.1
%
0.1
0.3
1.38
203
1680
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
594
4436
1.36
11.04
10.4
9.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
942
7511
1.28
10.92
3.9
4.1
%
0.1
0.1
1.69
239
1995
(3009343) pH of Capillary blood
677
5171
1.33
10.83
3.7
3.4
ph
7.4
7.4
0.11
93
705
(3002173) Hemoglobin [Mass/volume] in Arterial blood
978
7848
1.27
10.76
8.5
7.5
g/l
121.4
120.3
0.85
948
7558
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
379
2636
1.45
10.67
2.6
3.3
mg/l
60.9
40.9
0.28
314
2109
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1058
8587
1.26
10.57
2.2
2.2
g/l
0.2
0.2
0.07
985
8008
(3003434) Protein [Mass/volume] in Pleural fluid
170
983
1.74
10.55
1.6
1.5
g/l
31.2
32.9
0.95
154
888
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
683
5244
1.32
10.54
3.7
3.4
kpa
5.2
5.2
0.97
634
4839
(3021387) Prolactin [Units/volume] in Serum or Plasma
473
3437
1.39
10.43
1.6
1.6
mu/l
301.1
310.7
0.28
419
3080
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
400
2828
1.43
10.32
1.1
1.1
u/ml
4.5
6.5
0.65
53
353
(3034860) Kappa light chains.free [Mass/volume] in Serum
377
2639
1.44
10.27
2.6
3.3
mg/l
41.6
74.6
0.87
312
2108
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
685
5291
1.31
10.13
1.6
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
367
2567
1.44
10.05
2.6
3.2
ratio
1.8
2.2
0.22
18
212
(3022145) Colonoscopy Study observation
1267
10545
1.23
10.04
1.3
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
411
2936
1.41
10.02
1.2
1.3
u/ml
51.1
41.3
0.27
27
186
(3009214) Lutropin [Units/volume] in Serum or Plasma
348
2415
1.45
9.94
1.3
1.3
u/l
12.5
12.2
0.15
282
1964
(3011985) Renin [Units/volume] in Plasma
204
1260
1.63
9.92
2.0
1.4
mu/l
63.9
54.2
0.43
173
1123
(3023323) Follitropin [Units/volume] in Serum or Plasma
719
5613
1.30
9.84
1.4
1.3
iu/l
31.6
30.4
0.41
620
4860
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1750
15073
1.19
9.65
1.7
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
265
1752
1.52
9.63
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
190
1164
1.64
9.56
1.6
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
442
3234
1.38
9.39
4.0
3.7
mmol/l
25.0
25.0
0.10
405
2972
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
101
516
1.97
9.34
1.1
1.1
u/l
15.7
24.2
2.09
66
397
(3035880) pH of Pleural fluid
81
382
2.13
9.31
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1291
10849
1.21
9.27
1.6
1.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
71
319
2.23
9.20
21.9
3.5
mg/l
71.3
700.6
0.49
57
229
(3007566) Smooth muscle Ab [Titer] in Serum
369
2628
1.42
9.19
1.2
1.3
titre
90.4
126.3
0.71
28
247
(3034770) Mitochondria Ab [Titer] in Serum
368
2624
1.42
9.10
1.2
1.3
titre
1160.0
925.4
—
10
101
(3023199) Leukocytes [#/volume] in Pleural fluid
150
875
1.72
9.09
1.6
1.5
e6/l
1827.6
2942.6
0.73
112
634
(3002179) Metamyelocytes/100 leukocytes in Blood
883
7148
1.26
9.02
3.6
3.9
%
0.9
0.6
0.80
177
1555
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
46
171
2.70
8.95
1.2
1.1
pmol/l
1.9
5.0
—
8
20
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
100
519
1.93
8.86
1.1
1.1
u/l
67.6
83.3
2.27
69
408
(3012441) Differential panel - Pleural fluid
131
742
1.77
8.82
1.6
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
101
528
1.92
8.77
4.4
3.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
518
3929
1.33
8.74
3.7
3.2
mmol/l
25.6
25.3
1.20
496
3816
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
97
502
1.94
8.68
1.3
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
118
653
1.82
8.59
1.5
1.5
u/l
4.9
6.3
0.51
54
307
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
109
589
1.86
8.56
1.1
1.2
u/l
21.8
22.0
0.02
89
501
(3005322) IgE [Units/volume] in Serum or Plasma
785
6307
1.26
8.56
1.4
1.3
u/ml
177.7
208.2
0.57
733
5798
(3017732) Neutrophils [#/volume] in Blood
842
6839
1.25
8.35
2.7
2.8
e9/l
4.0
4.0
0.10
647
5333
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
48
190
2.53
8.28
1.6
1.4
ng/l
94.2
107.7
0.47
48
190
(1616796) Gas panel - Central venous blood
278
1918
1.46
8.26
3.0
3.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
533
4095
1.32
8.24
2.1
2.2
u/l
6607.6
5411.3
0.36
212
1657
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
109
607
1.80
7.82
1.1
1.2
u/l
76.4
84.4
0.38
91
533
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
86
444
1.94
7.80
1.6
1.7
nmol/l
2.2
4.3
1.14
73
364
(3048929) Epstein Barr virus Ab [Presence] in Serum
377
2776
1.37
7.77
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
322
2310
1.41
7.76
3.4
3.7
ph
7.4
7.4
2.31
275
1945
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
126
734
1.72
7.75
1.2
1.2
titre
159.4
175.4
0.08
17
140
(3035320) C reactive protein [Mass/volume] in Body fluid
118
675
1.76
7.74
2.6
2.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
206
1356
1.53
7.73
1.9
2.1
umol/l
5.4
6.8
1.03
142
1001
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
354
2585
1.38
7.68
1.2
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
828
6779
1.24
7.66
2.3
2.4
au/ml
18.9
26.0
1.25
36
395
(3021879) Hepatitis B virus core Ab [Presence] in Serum
853
7009
1.23
7.63
1.4
1.4
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
10
12
8.34
7.58
1.1
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
1471
12733
1.18
7.56
1.2
1.3
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
14
25
5.61
7.53
1.7
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
285
2012
1.43
7.53
2.0
2.2
g/l
130.7
127.9
0.99
180
1451
(3004451) EKG impression Narrative
79
402
1.97
7.48
1.2
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
241
1652
1.47
7.45
2.5
2.8
umol/l
30.9
34.0
1.42
190
1402
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
309
2220
1.40
7.40
1.2
1.3
u/ml
36.5
46.9
0.64
36
246
(3036782) Glucose [Moles/volume] in Pleural fluid
118
687
1.73
7.30
1.4
1.4
mmol/l
6.9
6.5
1.02
110
632
(3017446) Testosterone [Moles/volume] in Serum or Plasma
472
3629
1.31
7.30
2.3
2.1
nmol/l
11.1
11.3
0.21
413
3164
(3030313) Adrenal Ab [Titer] in Serum
28
89
3.15
7.24
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
654
5250
1.26
7.21
1.0
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
279
1983
1.42
7.12
3.5
3.8
mmol/l
2.6
2.6
0.02
199
1352
(3028308) Erythrocytes [#/volume] in Pleural fluid
131
791
1.66
7.10
1.5
1.5
e6/l
21332.5
61763.9
2.49
83
465
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
757
6191
1.24
7.08
1.2
1.3
au/ml
52.6
49.6
0.11
24
258
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
13
23
5.66
7.06
1.0
1.0
u/ml
0.9
0.2
—
6
9
(3011648) Oxygen content in Venous blood
111
642
1.74
7.05
2.2
2.5
%
11.5
10.9
0.74
111
642
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
236
1632
1.46
7.00
1.5
1.6
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
90
491
1.84
6.95
1.4
1.3
u/l
11.2
12.9
0.65
82
451
(40768806) Pleura Pathology biopsy report
130
788
1.66
6.95
1.8
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1969
17535
1.15
6.93
1.8
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
286
2053
1.40
6.91
1.4
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
207
1399
1.49
6.90
1.1
1.1
u/ml
3.0
3.3
0.16
94
666
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
110
639
1.73
6.89
1.3
1.3
u/l
315.6
365.9
0.31
103
604
(3036489) Thrombin time
445
3424
1.31
6.87
3.0
2.0
s
22.4
21.3
0.95
390
2938
(3021788) Differential panel - Synovial fluid
238
1655
1.45
6.86
1.6
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
376
2827
1.34
6.82
1.4
1.4
ug/g
283.1
279.5
0.13
231
1593
(3051611) Lipemic interference index of Serum or Plasma
150
949
1.59
6.76
4.2
3.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
476
3705
1.30
6.75
3.9
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
347
2582
1.35
6.74
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
242
1695
1.44
6.72
1.2
1.2
titre
72.0
162.6
—
5
39
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3936
36634
1.11
6.69
4.3
3.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
214
1467
1.47
6.66
1.6
1.6
g/l
0.8
0.7
0.40
156
1087
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
353
2642
1.35
6.61
3.5
2.5
g/l
3.6
3.6
0.10
336
2497
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
94
529
1.78
6.58
13.2
12.1
mmol/l
0.6
0.6
0.30
85
484
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
253
1794
1.42
6.58
1.5
1.4
—
—
—
0
0
(3036603) Volume of Urine
103
597
1.73
6.52
1.6
1.6
ml
1989.2
1883.3
0.31
28
131
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
359
2700
1.34
6.52
1.2
1.3
u/ml
20.3
6.3
0.94
47
445
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
213
1466
1.46
6.51
1.3
1.2
u/ml
5.0
3.2
0.73
88
486
(3023420) DNA double strand Ab [Units/volume] in Serum
166
1087
1.53
6.46
1.5
1.5
iu/ml
34.9
30.8
—
8
54
(3012565) Volume of 24 hour Urine
83
455
1.83
6.35
2.0
2.1
ml
1993.3
1931.2
0.25
71
411
(3024891) Influenza virus A+B Ag [Presence] in Specimen
325
2418
1.35
6.35
1.2
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
244
1732
1.42
6.33
6.6
5.3
iu/ml
252.4
1786.5
0.87
40
219
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
37
148
2.50
6.33
1.4
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
232
1633
1.43
6.30
1.5
1.4
u/ml
132.1
115.2
0.35
57
351
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
173
1153
1.51
6.22
1.5
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
207
1431
1.45
6.20
1.7
1.7
nmol/l
50.0
44.0
1.38
202
1387
(3004616) Nuclear Ab [Presence] in Serum
183
1235
1.49
6.19
1.2
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
400
3079
1.31
6.19
3.1
2.9
g/l
0.3
0.3
0.10
180
1149
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
352
2666
1.33
6.12
1.2
1.3
u/ml
9.6
6.6
0.17
31
284
(3045788) Cell count panel - Pleural fluid
113
686
1.65
6.07
1.6
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
368
2811
1.32
6.03
3.4
2.2
%
93.0
93.2
0.05
341
2597
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
249
1790
1.40
6.03
1.5
1.3
u/ml
12.5
21.7
—
5
36
(3044927) Protein electrophoresis panel - Urine
133
843
1.58
6.00
1.3
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
610
4978
1.24
5.87
2.5
2.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
270
1983
1.37
5.76
2.9
3.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
344
2623
1.32
5.73
4.0
2.4
%
183.9
187.3
0.31
323
2472
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
211
1488
1.43
5.72
1.5
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
192
1331
1.45
5.71
1.1
1.1
iu/ml
143.8
8431.8
0.64
41
324
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
270
1987
1.37
5.70
1.4
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
364
2800
1.31
5.70
1.4
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
526
4239
1.25
5.68
1.2
1.3
u/ml
0.8
1.2
0.58
38
392
(3019060) Gas panel - Arterial blood
663
5479
1.22
5.67
4.1
4.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
2048
18510
1.13
5.67
1.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
177
1210
1.47
5.66
1.3
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
227
1626
1.40
5.64
1.4
1.4
mmol/l
63.0
62.9
0.02
184
1294
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
65
344
1.89
5.60
2.3
1.8
%
166.8
167.2
0.01
60
319
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
82
467
1.76
5.59
2.1
1.8
%
145.1
138.4
0.31
76
434
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
176
1209
1.46
5.50
1.3
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
172
1179
1.47
5.44
1.4
1.3
pmol/l
322.6
314.9
0.07
138
920
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
125
802
1.56
5.40
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
176
1215
1.46
5.37
1.3
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
194
1373
1.42
5.20
1.2
1.1
%
111.0
119.5
2.69
171
1235
(44786800) Granulocytes/100 leukocytes in Body fluid
25
91
2.75
5.19
1.2
1.3
%
17.6
22.9
0.36
20
70
(3025468) Yersinia sp identified in Specimen by Organism specific culture
174
1208
1.45
5.18
1.3
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
83
486
1.71
5.16
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
117
749
1.57
5.13
1.2
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
241
1780
1.36
5.02
1.3
1.4
u/l
30.3
30.1
0.03
198
1462
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
117
753
1.56
5.02
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
153
1043
1.47
5.01
7.3
6.6
mg/l
12.0
11.8
0.20
142
961
(3024522) Salmonella sp identified in Specimen by Organism specific culture
175
1225
1.44
5.00
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
262
1963
1.34
4.98
1.5
1.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
41
192
2.14
4.98
1.3
1.3
mu/l
72.5
77.5
0.06
33
140
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
117
755
1.56
4.97
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
177
1245
1.43
4.93
1.3
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
116
749
1.55
4.92
1.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
199
1431
1.40
4.89
1.3
1.2
u/ml
5.4
4.0
0.88
98
606
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
397
3154
1.27
4.89
2.0
1.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
242
1799
1.35
4.85
1.3
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
140
945
1.49
4.83
1.5
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
256
1922
1.34
4.81
2.5
2.4
ug/min
84.8
83.1
0.03
162
1118
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
116
753
1.55
4.81
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
121
794
1.53
4.78
1.1
1.3
titre
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
48
243
1.98
4.76
4.9
4.9
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
115
748
1.54
4.73
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
326
2540
1.29
4.71
1.9
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
248
1860
1.34
4.71
3.4
2.9
kpa
8.3
8.2
0.08
230
1728
(40767503) Oxygen content in Capillary blood by calculation
249
1869
1.34
4.70
2.3
2.4
%
16.5
16.2
0.47
120
958
(3025941) Bacteria identified in Stool by Culture
670
5651
1.20
4.69
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1240
10992
1.14
4.62
1.5
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
3561
33465
1.09
4.55
3.0
2.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
197
1434
1.38
4.54
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
285
2194
1.31
4.52
1.2
1.3
u/ml
1.0
5.7
2.57
19
163
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
166
1175
1.42
4.50
2.2
2.1
mg/l
26.9
26.3
0.03
46
308
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
263
2004
1.32
4.50
1.5
1.3
e6/l
53.3
30.5
0.43
203
1549
(4062490)
139
952
1.47
4.50
1.5
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
263
2005
1.32
4.48
1.6
1.4
e6/l
1101.3
3234.7
0.56
218
1633
(3003327) Ova and parasites identified in Stool by Light microscopy
426
3453
1.24
4.45
1.7
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
119
792
1.51
4.44
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1547
13945
1.13
4.43
5.0
4.9
ug/l
2.5
3.2
1.00
1334
12466
(3016650) Hepatitis A virus Ab [Presence] in Serum
198
1449
1.37
4.43
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
8303
80947
1.10
4.39
24.1
17.2
g/l
331.1
331.5
4.67
8252
80325
(1761482) Bacteria [#/volume] in Urine by Culture
289
2241
1.30
4.36
4.8
4.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
35
163
2.15
4.35
3.9
6.2
%
69.7
69.7
0.00
29
126
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
448
3661
1.23
4.35
4.7
3.8
%
47.8
48.4
0.18
442
3620
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
278
2146
1.30
4.34
1.3
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
107
701
1.53
4.30
1.0
1.1
mg/l
302.5
296.3
0.38
99
626
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
358
2857
1.26
4.30
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
274
2116
1.30
4.27
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
558
4675
1.20
4.23
3.9
3.4
—
—
—
0
0
(4035726)
973
8536
1.15
4.22
1.4
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
256
1965
1.31
4.18
1.2
1.2
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
11
27
4.08
4.15
1.0
1.0
u/ml
0.2
0.1
—
6
15
(4094501)
300
2354
1.28
4.15
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
124
845
1.47
4.15
1.7
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
742
6385
1.17
4.15
3.5
3.0
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
137
952
1.44
4.14
1.5
1.4
g/l
2.9
2.8
0.29
94
651
(3023383) Lactate [Moles/volume] in Pleural fluid
42
214
1.97
4.14
1.2
1.3
mmol/l
2.3
3.4
1.90
35
194
(3024139) IgG subclass 3 [Mass/volume] in Serum
137
953
1.44
4.12
1.5
1.4
g/l
0.4
0.4
1.00
93
651
(3049717) Cytology report of Urine Cyto stain
347
2774
1.26
4.12
2.6
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
81
503
1.61
4.12
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
78
482
1.62
4.05
1.2
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
25
104
2.41
4.04
8.5
11.8
mmol/l
5.0
5.1
0.08
25
104
(4306422)
195
1447
1.35
4.03
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
90
577
1.56
4.01
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
224
1699
1.32
4.00
1.3
1.2
u/ml
279.7
280.9
0.02
146
1070
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
142
1002
1.42
3.97
1.2
1.1
%
92.2
94.6
0.46
133
939
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
169
1229
1.38
3.97
1.1
1.1
g/l
1.5
1.5
0.16
155
1103
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1286
11544
1.13
3.95
4.7
4.3
%
33.3
32.9
0.57
923
7788
(3027135) IgG subclass 1 [Mass/volume] in Serum
136
954
1.43
3.93
1.5
1.4
g/l
6.3
6.8
1.07
90
655
(43055442) Apixaban [Mass/volume] in Serum or Plasma
26
112
2.32
3.91
1.5
1.5
ug/l
118.7
117.8
0.01
20
99
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
41
212
1.94
3.89
1.1
1.1
pmol/l
294.4
329.2
0.17
29
153
(42529406) Shigella sp [Presence] in Stool by Culture
358
2893
1.25
3.89
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
913
8029
1.15
3.84
2.9
3.0
ug/l
0.7
0.8
0.34
605
5357
(3028271) Lactate [Moles/volume] in Capillary blood
189
1408
1.35
3.83
1.8
1.8
mmol/l
1.6
1.7
0.66
184
1380
(3044290) Cell count panel - Cerebral spinal fluid
243
1877
1.30
3.83
1.5
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
135
952
1.42
3.81
2.0
1.8
pmol/l
183.4
184.4
0.03
118
895
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
353
2856
1.24
3.81
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
32
153
2.09
3.77
1.2
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
88
572
1.54
3.72
1.0
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
25
109
2.30
3.67
1.3
1.2
mmol/l
1.4
1.4
0.01
15
71
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
134
951
1.41
3.66
1.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
355
2888
1.24
3.66
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
189
1420
1.34
3.64
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
168
1241
1.36
3.62
1.3
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
88
577
1.53
3.59
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
104
708
1.47
3.56
1.5
1.3
mmol/l
2.2
2.0
0.58
96
662
(3008898) HLA-B27 [Presence]
419
3480
1.21
3.54
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
275
2183
1.27
3.53
1.8
1.6
e6/l
12901.1
12014.1
0.15
201
1567
(3029937) Albumin [Presence] in Urine by Test strip
2726
25565
1.09
3.51
4.4
4.2
estimate
0.0
0.0
0.09
1041
8778
(3008295) Osmolality of Serum or Plasma
131
934
1.41
3.51
1.5
1.4
mosm/kgh2o
281.5
277.4
1.03
96
705
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
175
1310
1.34
3.48
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
129
919
1.41
3.47
1.8
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
99
671
1.48
3.47
1.2
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
103
705
1.47
3.44
1.4
1.3
u/ml
0.4
1.1
1.14
55
314
(3041918) Cholesterol [Moles/volume] in Pleural fluid
28
133
2.11
3.38
1.2
1.2
mmol/l
1.5
1.8
0.50
17
80
(40768443) Skin Pathology biopsy report
505
4289
1.19
3.36
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
71
451
1.58
3.36
3.2
2.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
65
405
1.61
3.33
2.2
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
222
1730
1.29
3.32
1.8
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
336
2750
1.23
3.31
2.5
2.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
177
1340
1.33
3.28
2.7
2.6
u/ml
383.0
1967.3
—
9
75
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
391
3255
1.21
3.25
2.2
1.9
ug/l
5.0
2.2
0.35
340
2867
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
132
956
1.39
3.25
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
454
3835
1.19
3.23
1.6
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
780
6874
1.14
3.23
1.3
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
254
2022
1.26
3.22
1.3
1.2
mmol/l
3.9
3.7
1.59
241
1904
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
122
874
1.40
3.21
1.4
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
107
751
1.43
3.17
1.6
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
188
1444
1.31
3.16
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
279
2251
1.25
3.15
2.3
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
52
312
1.67
3.11
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
113
804
1.41
3.11
3.9
3.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
171
1300
1.32
3.10
1.2
1.2
u/l
38.9
36.0
0.06
155
1132
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
184
1414
1.31
3.09
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
801
9021
0.88
3.08
1.3
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
284
2303
1.24
3.08
1.4
1.3
mg/l
618.6
514.0
0.62
268
2195
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
84
566
1.49
3.08
1.2
1.3
titre
70.0
57.3
—
9
45
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
290
2358
1.24
3.06
1.5
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
79
526
1.51
3.06
2.2
2.1
%
95.8
100.1
0.46
74
476
(3006922) Hepatitis E virus Ab [Presence] in Serum
93
641
1.45
3.04
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
130
951
1.37
3.04
3.7
3.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
151
1131
1.34
3.04
1.7
1.6
%
55.4
55.5
0.01
97
686
(3044941) Cell count panel - Synovial fluid
182
1403
1.30
3.00
1.6
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
411
3469
1.19
2.98
4.6
4.8
%
1.7
1.6
0.64
390
3248
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1078
9744
1.12
2.98
3.1
3.8
ug/l
10.6
25.3
2.39
842
7706
(3016018) Differential panel - Cerebral spinal fluid
136
1007
1.35
2.96
1.6
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
52
317
1.64
2.95
1.3
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
13
46
2.83
2.91
1.3
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
173
1332
1.30
2.89
1.2
1.3
u/ml
71.4
57.5
—
8
109
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
156
1184
1.32
2.89
1.4
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
97
682
1.43
2.88
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
137
1022
1.34
2.86
2.5
2.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
259
2105
1.24
2.78
3.2
2.9
mmol/l
25.2
25.0
0.28
231
1843
(3011397) Hemoglobin [Presence] in Urine by Test strip
2408
22666
1.08
2.78
3.8
3.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
63
409
1.54
2.78
1.1
1.1
iu/ml
194.4
162.6
0.28
63
402
(3017569) Oxygen content in Arterial blood
61
394
1.55
2.75
2.0
2.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
61
395
1.55
2.73
2.6
2.0
ug/min
179.2
105.1
—
6
87
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
33
181
1.83
2.72
1.8
2.4
mmol/l
7.4
7.4
0.02
21
107
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
71
476
1.49
2.71
2.0
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
109
794
1.38
2.67
1.2
1.2
u/ml
75.6
65.5
—
5
43
(3040151) Glucose [Moles/volume] in Capillary blood
131
983
1.34
2.65
12.8
5.1
mmol/l
7.7
7.6
0.06
108
811
(3008037) Lactate [Moles/volume] in Venous blood
225
1812
1.25
2.65
4.1
3.0
mmol/l
1.6
1.6
0.56
217
1769
(44790047)
126
941
1.34
2.64
1.6
1.5
—
—
—
0
0
(44806118)
126
941
1.34
2.64
1.6
1.5
—
—
—
0
0
(44790049)
126
941
1.34
2.64
1.6
1.5
—
—
—
0
0
(44790048)
126
941
1.34
2.64
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
144
1097
1.32
2.63
1.3
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1214
11123
1.10
2.62
4.1
4.2
%
23.0
21.8
1.50
535
5362
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
84
587
1.43
2.61
1.2
1.3
titre
1302.0
389.5
—
5
40
(3045683) HLA typing for celiac disease panel - Blood or Tissue
87
612
1.42
2.61
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
95
679
1.40
2.61
1.2
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
104
755
1.38
2.61
1.4
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
104
755
1.38
2.61
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
104
755
1.38
2.61
1.4
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
78
538
1.45
2.60
1.3
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
521
4539
1.15
2.60
3.2
2.6
e6/l
0.2
0.3
1.16
507
4390
(3020491) Glucose [Moles/volume] in Blood
96
688
1.40
2.60
1.8
1.8
mmol/l
6.7
6.5
0.21
77
492
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
109
798
1.37
2.60
1.2
1.2
u/ml
81.9
41.4
—
9
64
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
65
433
1.50
2.57
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
65
433
1.50
2.57
1.5
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
402
3439
1.18
2.54
4.6
4.8
%
0.9
0.9
0.02
382
3222
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
37
215
1.72
2.54
1.5
1.1
%
87.9
81.6
0.37
18
48
(3021901) Oxygen saturation in Capillary blood
190
1514
1.26
2.48
2.8
2.7
—
—
—
0
0
(3019977) pH of Arterial blood
70
478
1.47
2.47
2.4
2.9
ph
7.4
7.4
0.22
31
165
(3033705) Calcium.ionized [Moles/volume] in Venous blood
134
1021
1.32
2.47
3.2
2.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
23
116
1.98
2.44
1.2
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
595
5258
1.14
2.44
6.2
6.7
mmol/l
24.6
24.7
0.06
556
4890
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
71
488
1.46
2.43
1.1
1.1
u/ml
11.8
20.5
—
5
41
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
61
407
1.50
2.42
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
61
407
1.50
2.42
1.3
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
77
539
1.43
2.40
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
43
265
1.63
2.40
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
1034
9445
1.10
2.39
1.4
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
182
1452
1.26
2.37
3.7
3.3
%
1.1
1.5
0.81
141
1136
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
375
3212
1.17
2.36
2.8
3.3
u/ml
266.0
2368.2
1.60
311
2708
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
581
5139
1.14
2.36
1.5
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
75
525
1.43
2.35
1.4
1.4
umol/l
34.4
24.8
1.39
70
498
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
22
111
1.98
2.35
1.7
1.4
%
10.3
9.2
0.07
15
57
(3011335) Digoxin [Mass/volume] in Serum or Plasma
16
71
2.26
2.33
3.4
2.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
85
610
1.40
2.32
2.4
2.6
e9/l
0.2
0.2
0.42
75
523
(4010399)
756
6806
1.12
2.30
1.5
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
34
200
1.70
2.27
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1139
10486
1.10
2.25
1.6
1.7
%
1.4
1.4
1.09
990
9238
(3047181) Lactate [Moles/volume] in Blood
318
2700
1.18
2.24
4.9
5.5
mmol/l
1.3
1.3
0.02
282
2380
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
183
1473
1.25
2.22
1.1
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
75
531
1.42
2.22
1.7
1.5
ug/l
15.2
8.2
0.64
66
474
(3017704) Immunofixation for Urine
62
425
1.46
2.19
2.0
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
55
368
1.50
2.18
28.5
26.7
ug/l
117.8
113.6
0.18
41
304
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
185
1495
1.24
2.18
1.4
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
31
180
1.72
2.18
1.3
1.2
ug/l
14.3
289.8
1.41
19
105
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
28
158
1.77
2.16
1.1
1.0
ug/l
79.9
76.2
0.16
20
135
(3025130) Human papilloma virus identified in Specimen
205
1677
1.23
2.16
1.7
1.7
—
—
—
0
0
(1002224) Polysomnography panel
427
3725
1.15
2.15
1.1
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
6
14
4.29
2.15
1.0
1.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
16
74
2.16
2.14
1.2
1.1
u/l
16.4
23.5
1.03
11
54
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
26
144
1.81
2.14
1.9
1.6
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
35
212
1.65
2.12
1.4
1.1
%
79.1
70.7
0.42
15
43
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
13
55
2.37
2.11
1.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
109
828
1.32
2.11
2.7
2.8
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
87
639
1.36
2.10
2.4
2.5
e6/l
479.7
521.4
0.37
74
529
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
49
323
1.52
2.10
2.4
2.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
92
682
1.35
2.10
1.5
1.5
u/ml
31.8
20.0
0.68
12
138
(3052592) Norovirus Ag [Presence] in Stool
30
176
1.71
2.05
1.3
1.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
57
391
1.46
2.03
1.4
2.1
umol/l
115.0
138.7
0.25
27
218
(3004716) Salmonella sp identified in Stool by Organism specific culture
576
5149
1.12
2.02
1.4
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
80
584
1.37
2.02
1.0
1.1
u/ml
0.5
1.7
1.12
24
171
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
160
1285
1.25
2.02
1.3
1.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
51
343
1.49
2.00
1.9
2.0
%
29.8
28.1
0.37
44
328
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
50
335
1.49
2.00
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
22
119
1.85
1.96
1.2
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
10
39
2.57
1.92
1.2
1.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
68
488
1.40
1.91
2.8
2.6
—
29.9
—
0
9
(3016038) Potassium [Moles/volume] in Urine
82
607
1.35
1.91
1.2
1.2
mmol/l
31.4
33.5
0.45
70
503
(3019832) Treponema pallidum Ab [Presence] in Serum
1038
9593
1.09
1.91
1.6
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
65
463
1.41
1.91
1.1
1.3
nmol/l
130.2
135.5
0.38
65
463
(3006245) CD3-CD19+ cells/100 cells in Blood
51
347
1.47
1.91
1.9
2.1
%
10.4
9.8
0.12
44
327
(3033923) Metanephrine [Moles/time] in 24 hour Urine
34
211
1.61
1.90
1.1
1.1
umol/24h
0.5
0.7
1.53
16
95
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
78
2.05
1.90
1.4
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
49
331
1.48
1.90
3.0
2.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
82
608
1.35
1.90
1.1
1.1
ratio
1.1
1.1
0.07
32
210
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
83
617
1.35
1.89
2.4
2.7
e6/l
641.2
744.6
0.65
33
270
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
264
2247
1.18
1.87
2.9
3.2
mg/l
1.6
1.5
1.96
239
2068
(3010370) Gastrin [Moles/volume] in Serum or Plasma
25
144
1.74
1.84
2.3
1.9
pmol/l
35.4
50.5
0.71
19
125
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
89
672
1.33
1.84
1.9
2.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
69
502
1.38
1.81
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
51
352
1.45
1.79
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
40
263
1.52
1.78
1.6
1.4
%
70.1
62.4
0.69
32
221
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
78
581
1.34
1.77
1.4
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
205
1717
1.20
1.76
4.4
3.1
mmol/l
7.4
7.5
0.18
199
1678
(3022475) Manganese [Moles/volume] in Blood
14
67
2.09
1.75
1.2
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
38
248
1.53
1.75
1.9
2.1
e6/l
210.4
199.1
0.06
26
130
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
51
355
1.44
1.73
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
36
233
1.55
1.72
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
79
593
1.33
1.72
1.4
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
22
125
1.76
1.71
1.1
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
64
465
1.38
1.71
1.4
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
64
465
1.38
1.71
1.4
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
64
465
1.38
1.71
1.4
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
19
103
1.85
1.71
1.8
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
83
630
1.32
1.68
2.0
2.3
ml
608.8
632.0
0.24
65
429
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
64
467
1.37
1.67
1.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
64
467
1.37
1.67
1.4
1.8
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
63
459
1.37
1.66
1.2
1.2
%
61.3
64.8
—
8
52
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
95
736
1.29
1.66
1.3
1.3
nmol/l
1.4
1.5
0.22
81
664
(40757373) Influenza virus identified in Isolate
28
172
1.63
1.66
1.7
1.6
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
19
3.16
1.66
1.0
1.2
%
3.0
2.5
—
6
19
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
8
31
2.58
1.65
1.3
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
125
1003
1.25
1.65
1.1
1.1
—
4.1
—
0
10
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
63
460
1.37
1.65
1.3
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
104
817
1.28
1.64
1.1
1.2
nmol/l
382.3
366.1
0.33
83
709
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
20
112
1.79
1.64
3.0
2.8
u/field
0.8
0.8
0.00
20
112
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
203
1714
1.19
1.62
1.4
1.4
nmol/l
0.4
0.4
0.06
149
1299
(3016750) Collection duration of Urine
64
470
1.36
1.62
1.8
2.2
min
498.4
497.2
0.04
53
352
(21494890) Protein electrophoresis panel - 24 hour Urine
104
819
1.27
1.61
1.7
2.2
—
—
—
0
0
(3024471) HLA-A [Type]
38
254
1.50
1.59
1.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
46
320
1.44
1.59
1.1
1.2
%
114.6
111.1
0.48
41
283
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
40
271
1.48
1.58
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
495
4462
1.11
1.57
2.0
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
37
247
1.50
1.56
1.0
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
51
363
1.41
1.56
1.1
1.1
ng/l
1081.5
569.6
—
10
78
(3026389) Candida sp identified in Specimen by Organism specific culture
190
1603
1.19
1.55
1.3
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
107
1.78
1.54
5.1
5.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
286
3271
0.87
1.54
1.9
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
128
1040
1.23
1.53
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
24
145
1.66
1.53
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
181
1523
1.19
1.52
1.6
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
34
504
0.67
1.52
19.8
11.7
nmol/l
858.8
819.2
0.19
34
484
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
6
21
2.86
1.50
2.8
3.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
520
1.33
1.50
1.3
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
16
86
1.86
1.50
1.9
2.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
331
2932
1.13
1.44
1.4
1.5
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
16
3.13
1.44
1.0
3.0
mu/l
1.7
2.0
—
5
16
(3011412) CD3 cells [#/volume] in Blood
112
905
1.24
1.43
2.3
2.4
e9/l
1.3
1.2
0.43
68
543
(3023419) Bacteria identified in Sputum by Culture
128
1051
1.22
1.41
2.8
2.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
183
1554
1.18
1.41
1.2
1.1
au/ml
1.0
10.9
—
5
85
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
158
1325
1.20
1.41
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
116
944
1.23
1.40
1.2
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
331
2939
1.13
1.39
1.6
1.6
iu/ml
0.2
7.5
0.73
66
635
(44816559) Phosphatidylethanol [Mass/volume] in Blood
194
1659
1.17
1.38
1.2
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
17
96
1.77
1.38
1.1
1.2
umol/24h
1.5
1.7
0.44
17
96
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
17
96
1.77
1.38
1.2
1.3
u/l
25.1
375.8
0.58
11
70
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
96
1.77
1.38
1.3
1.1
—
—
—
0
0
(4268621)
121
991
1.22
1.38
2.5
2.2
—
—
—
0
0
(3025315) Body weight
13
67
1.94
1.38
5.2
3.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
191
1632
1.17
1.38
2.2
1.9
nmol/l
0.9
0.8
0.27
154
1366
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
20
119
1.68
1.37
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
122
1001
1.22
1.37
1.1
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
380
3409
1.12
1.35
1.5
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
33
223
1.48
1.35
1.7
1.4
%
4.0
2.6
0.27
26
189
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
308
2729
1.13
1.35
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
477
4333
1.11
1.35
1.4
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
234
0.56
1.33
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
51
378
1.35
1.28
1.5
2.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
306
2722
1.13
1.28
1.4
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
47
344
1.37
1.27
1.1
1.2
g/l
0.3
0.3
0.70
39
270
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
31
210
1.48
1.27
1.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
20
122
1.64
1.27
1.4
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
50
370
1.35
1.27
1.4
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
50
370
1.35
1.27
1.4
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
135
1130
1.20
1.26
2.1
2.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
47
345
1.36
1.25
1.2
1.1
%
101.7
111.7
0.91
42
307
(40757494) Bilirubin.total [Moles/volume] in Blood
60
458
1.31
1.24
1.9
2.3
umol/l
14.9
18.3
—
8
45
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
307
2737
1.13
1.24
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
307
2739
1.12
1.23
1.4
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
9
45
2.00
1.23
1.0
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
103
842
1.23
1.23
1.7
1.5
%
29.7
33.5
0.44
63
490
(3017354) Segmented neutrophils/100 leukocytes in Blood
108
888
1.22
1.22
3.4
3.2
%
58.6
56.8
0.29
72
574
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
11
56
1.97
1.22
1.2
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
93
753
1.24
1.21
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
132
1108
1.19
1.21
1.2
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
28
188
1.49
1.20
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
31
213
1.46
1.20
1.1
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
86
693
1.24
1.18
1.1
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
82
658
1.25
1.17
1.1
1.1
iu/ml
11.2
8.9
0.20
17
161
(3039000) Anion gap in Blood
215
1883
1.14
1.16
5.6
6.5
mmol/l
11.9
11.2
2.03
197
1684
(40760410) HLA-B [Type] by High resolution
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
215
1884
1.14
1.16
5.6
6.5
mmol/l
104.7
105.1
0.43
197
1685
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
105
867
1.21
1.15
1.1
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
42
308
1.36
1.15
1.2
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
58
447
1.30
1.14
1.1
1.0
%
91.1
93.4
0.28
43
355
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
45
334
1.35
1.14
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
108
897
1.21
1.12
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
55
422
1.30
1.12
1.8
2.2
—
—
—
0
0
(4211845)
67
528
1.27
1.12
3.2
3.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
40
2.00
1.12
1.3
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
60
468
1.28
1.09
2.3
2.8
%
43.3
40.5
0.58
24
168
(3036071) Salmonella sp Ab [Titer] in Serum
40
294
1.36
1.09
1.1
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
21
2.38
1.09
1.4
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
57
442
1.29
1.08
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
397
3624
1.10
1.07
2.2
1.7
mg/l
4.1
3.5
0.57
313
2546
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
33
236
1.40
1.06
1.0
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
33
2.12
1.05
1.0
1.1
nmol/l
194.3
280.9
—
7
33
(3006462) Nitrate [Presence] in Urine
62
489
1.27
1.04
2.8
3.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
189
1657
1.14
1.04
1.0
1.1
u/ml
3.7
4.8
0.70
100
830
(3012494) Peanut IgE Ab [Units/volume] in Serum
37
271
1.37
1.04
1.0
1.1
u/ml
0.3
1.9
1.40
16
149
(43055514) Macroprolactin [Presence] in Serum or Plasma
33
237
1.39
1.04
1.1
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
16
98
1.63
1.03
1.9
2.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
72
580
1.24
1.02
1.7
1.5
u/l
6.3
6.0
0.10
55
491
(4024509)
120
1018
1.18
1.02
1.6
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
25
171
1.46
1.01
1.2
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
51
394
1.30
1.01
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1040
9871
1.06
1.01
1.9
1.9
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
14
83
1.69
1.01
1.9
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
22
147
1.50
1.00
5.8
7.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1184
11289
1.05
0.98
1.7
1.8
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
44
335
1.31
0.98
1.2
1.1
%
81.6
93.6
0.82
20
141
(3009466) Valproate [Moles/volume] in Serum or Plasma
140
1208
1.16
0.97
5.3
5.2
umol/l
381.5
365.6
0.72
116
1050
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
84
1.67
0.97
1.9
2.8
mg/l
3.0
1.0
—
9
59
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1161
11069
1.05
0.97
2.0
2.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
15
92
1.63
0.97
1.1
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
125
1071
1.17
0.96
1.9
2.1
pg
32.0
32.6
0.78
125
1058
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
99
832
1.19
0.95
1.4
1.3
mmol/l
14.2
11.7
1.17
29
178
(3027570) Oxalate [Moles/time] in 24 hour Urine
9
51
1.77
0.94
1.6
1.5
umol/24h
385.1
307.5
—
9
51
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
27
2.22
0.93
1.2
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
32
234
1.37
0.93
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
32
234
1.37
0.93
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
32
234
1.37
0.93
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
32
234
1.37
0.93
1.1
1.1
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
9
52
1.73
0.92
2.2
1.7
umol/l
1.1
0.8
—
9
33
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
9
52
1.73
0.92
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
24
167
1.44
0.91
6.3
7.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
166
1459
1.14
0.91
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
37
278
1.33
0.91
1.9
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
28
201
1.39
0.91
1.1
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
44
340
1.30
0.90
1.2
1.1
%
84.9
91.9
0.52
19
136
(3038177) Helicobacter pylori Ab [Presence] in Serum
190
1687
1.13
0.90
1.2
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
15
231
0.65
0.89
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
179
1585
1.13
0.88
1.0
1.1
u/ml
0.6
1.1
1.02
69
640
(3051101) Glucose [Moles/volume] in Cord blood
9
155
0.58
0.88
4.6
6.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
89
750
1.19
0.85
1.2
1.1
mg/l
41.6
38.8
0.18
69
635
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
39
299
1.31
0.85
1.1
1.2
%
24.2
21.5
—
5
44
(3014599) Egg white IgE Ab [Units/volume] in Serum
69
568
1.22
0.84
1.0
1.0
u/ml
8.0
0.9
0.43
16
134
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
31
1.94
0.84
3.5
9.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
189
1687
1.12
0.83
1.7
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
235
2124
1.11
0.83
3.1
3.6
u/ml
39.8
37.4
0.06
228
2058
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
19
129
1.47
0.83
1.4
1.1
—
—
—
0
0
(4146454)
107
919
1.17
0.83
3.3
2.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
165
1462
1.13
0.82
1.2
1.4
ug/l
2.4
3.8
2.66
141
1280
(4015189)
31
231
1.34
0.82
2.3
2.4
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
16
105
1.52
0.81
1.2
1.2
mmol/l
6.6
6.3
—
6
51
(3020891) Body temperature
368
3405
1.08
0.80
4.6
4.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
42
329
1.28
0.80
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
205
1845
1.11
0.80
1.1
1.1
u/ml
2.2
1.4
0.46
76
697
(40762814) Titanium [Mass/volume] in Blood
21
147
1.43
0.79
2.5
2.2
ug/l
8.1
3.8
—
7
59
(3002523) Influenza virus A Ag [Presence] in Specimen
164
1457
1.13
0.79
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
30
224
1.34
0.79
1.2
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
10
58
1.72
0.79
5.0
5.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
68
564
1.21
0.79
1.3
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
40
312
1.28
0.79
1.1
1.1
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
4.6
—
4.9
—
0
18
(3019150) Specific gravity of Urine by Refractometry
2126
20662
1.04
0.77
4.5
4.2
kg/l
1.0
1.0
0.08
382
3136
(4027681)
69
575
1.20
0.77
1.3
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
48
385
1.25
0.76
1.2
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
324
2990
1.09
0.76
3.7
3.9
mmol/l
1.3
1.4
0.95
319
2940
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(4133840)
15
221
0.68
0.75
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
65
540
1.20
0.75
1.3
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
67
1.64
0.75
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
13
83
1.57
0.74
1.7
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
227
1.32
0.74
1.1
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
36
280
1.29
0.73
2.4
3.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
268
2458
1.09
0.73
1.5
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
51
415
1.23
0.72
3.5
3.4
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
73
616
1.19
0.72
1.8
1.6
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
6
109
0.55
0.72
1.2
1.9
mg/l
1.5
1.5
—
6
91
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
75
635
1.18
0.72
1.1
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
13
84
1.55
0.71
1.2
1.0
—
6.5
—
0
11
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
11
68
1.62
0.71
1.1
1.1
u/l
29.5
9.9
0.37
11
68
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
541
5732
0.94
0.71
1.5
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
159
1424
1.12
0.70
1.8
2.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
152
1359
1.12
0.69
1.5
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
63
527
1.20
0.69
1.1
1.1
u/l
1.1
1.1
0.16
31
247
(3004446) Plasmodium sp identified in Blood by Light microscopy
14
93
1.51
0.69
2.8
2.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
83
712
1.17
0.69
1.9
2.1
%
11.5
13.7
1.45
44
322
(3009871) Measles virus Ab [Titer] in Serum
42
337
1.25
0.68
1.6
1.7
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
85
731
1.16
0.68
1.9
2.1
%
73.3
73.3
0.01
76
703
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
7
42
1.67
0.68
1.0
1.2
u/l
274.9
388.8
—
7
35
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
59
1.53
0.68
1.1
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
61
510
1.20
0.68
2.3
1.8
u/field
1.2
2.3
2.26
45
355
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
117
0.60
0.67
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
45
365
1.23
0.67
1.0
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
15
102
1.47
0.67
1.3
1.3
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
23
170
1.35
0.67
4.7
4.5
u/l
32.5
43.5
—
10
58
(3025018) Bordetella pertussis Ab [Titer] in Serum
70
595
1.18
0.66
1.2
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
20
145
1.38
0.65
1.6
2.5
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
5
29
1.72
0.64
1.4
1.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
47
386
1.22
0.63
12.4
12.3
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
53
441
1.20
0.63
1.7
1.5
%
4.5
3.6
0.19
14
88
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
17
121
1.41
0.62
2.8
2.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
49
1.63
0.62
8.0
4.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
10
63
1.59
0.61
1.1
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
10
63
1.59
0.61
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
31
244
1.27
0.61
1.9
1.7
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
21
156
1.35
0.60
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
21
156
1.35
0.60
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
156
1.35
0.60
1.0
1.1
—
—
—
0
0
(3021367) Citalopram [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
108.1
—
0
11
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
80
694
1.15
0.60
1.5
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
304
2837
1.07
0.59
2.0
1.7
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
64
1.56
0.58
1.4
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
8
54
1.48
0.57
1.1
1.8
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
8
54
1.48
0.57
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
21
159
1.32
0.55
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
29
230
1.26
0.55
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
23
177
1.30
0.54
1.2
2.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
83
730
1.14
0.53
1.1
1.1
mg/l
253.9
246.1
0.13
68
647
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
9
61
1.48
0.53
1.2
1.1
mmol/l
8.7
8.1
—
9
61
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
813
8442
0.96
0.53
1.7
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
96
853
1.13
0.53
1.4
1.4
e6/l
82975.5
113188.3
0.24
65
579
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
704
6763
1.04
0.51
3.2
3.5
u/ml
76.7
58.5
0.36
674
6532
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
49
416
1.18
0.50
1.4
2.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
38
315
1.21
0.50
1.7
1.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
41
1.46
0.50
1.5
2.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
32
390
0.82
0.49
3.4
3.9
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
22
280
0.79
0.49
1.3
1.3
%
65.8
52.4
0.88
17
236
(3024263) Appearance of Synovial fluid
53
454
1.17
0.49
2.8
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
246
2298
1.07
0.49
1.4
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
39
325
1.20
0.49
2.2
2.9
umol/l
31.5
28.1
0.94
26
243
(3051387) C reactive protein [Mass/volume] in Capillary blood
214
1992
1.08
0.48
4.0
3.5
mg/l
22.4
25.9
0.80
116
1242
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
706
6798
1.04
0.48
1.8
1.8
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
10
143
0.70
0.47
7.1
8.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
35
290
1.21
0.47
1.7
1.5
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
85
1.41
0.46
2.7
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
34
282
1.21
0.46
3.1
3.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
165
1524
1.08
0.46
1.1
1.1
u/ml
1.7
1.6
0.07
33
376
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
13
94
1.38
0.45
1.3
1.1
—
—
—
0
0
(4212803)
12
86
1.40
0.44
1.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
25
202
1.24
0.43
1.2
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
21
263
0.80
0.43
1.2
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
21
166
1.27
0.43
1.1
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
50
434
1.15
0.42
1.1
1.1
miu/ml
1559.5
1536.6
0.05
50
434
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
44
378
1.16
0.42
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
78
870
0.90
0.42
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
237
2230
1.06
0.41
1.4
1.4
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
16
0.00
0.41
0.0
1.1
—
35.6
—
0
16
(3016244) Insulin [Units/volume] in Serum or Plasma
67
595
1.13
0.41
3.4
3.4
mu/l
26.7
27.4
0.06
61
565
(3047352) Trisomy 18 risk [Likelihood] in Fetus
238
2241
1.06
0.41
1.4
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
50
435
1.15
0.41
1.0
1.1
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
17
0.00
0.40
0.0
1.2
—
69.7
—
0
17
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
26
213
1.22
0.40
1.2
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
18
0.00
0.40
0.0
2.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
104
0.67
0.39
1.0
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
106
1.32
0.39
1.4
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
10
137
0.73
0.39
1.2
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
137
0.73
0.39
1.1
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
45
391
1.15
0.38
3.1
2.3
mmol/l
9.9
9.2
0.67
33
297
(3000034) Microalbumin [Mass/volume] in Urine
92
837
1.10
0.38
2.5
2.9
mg/l
25.0
40.4
0.73
59
597
(3037556) Urate [Mass/volume] in Serum or Plasma
31
261
1.19
0.38
1.3
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
67
599
1.12
0.38
1.2
1.5
promille
1.3
1.2
0.36
55
455
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
37
430
0.86
0.37
1.9
1.8
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(44806071)
17
134
1.27
0.36
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
53
468
1.13
0.36
1.6
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
39
337
1.16
0.36
1.2
1.4
pmol/l
95.5
131.1
0.17
22
117
(3037692) Legionella sp identified in Specimen by Organism specific culture
36
309
1.17
0.36
1.6
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
23
189
1.22
0.36
1.1
1.2
—
—
—
0
0
(4281824)
122
1317
0.93
0.35
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
99
1.31
0.35
1.3
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
42
366
1.15
0.35
2.0
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
33
384
0.86
0.34
1.8
2.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
34
292
1.16
0.34
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
32
274
1.17
0.33
1.4
1.9
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
18
145
1.24
0.33
1.8
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
739
7596
0.97
0.33
3.9
3.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
54
482
1.12
0.33
1.7
1.6
nmol/l
1.2
1.3
0.24
39
376
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
14
111
1.26
0.30
7.1
7.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
27
231
1.17
0.29
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
87
803
1.08
0.29
1.6
1.6
mmol/l
7.7
7.7
0.03
56
487
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
41
363
1.13
0.29
1.5
1.5
iu/ml
—
1813430.0
—
0
21
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
43
382
1.13
0.29
2.2
2.3
umol/l
51.2
52.5
0.11
31
313
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
7
57
1.23
0.29
1.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
184
0.81
0.28
1.3
2.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
27
232
1.16
0.28
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
23
195
1.18
0.28
1.1
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
57
517
1.10
0.28
2.1
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
125
1174
1.07
0.27
2.4
2.3
u/ml
440.6
1351.8
0.51
119
1110
(3048879) Bone marrow aspiration report
20
236
0.85
0.26
1.4
2.0
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
27
234
1.15
0.26
2.6
3.1
ng/l
74.8
125.7
—
10
93
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
206
1.17
0.26
1.1
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
21
178
1.18
0.26
1.2
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
30
263
1.14
0.25
1.3
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
18
151
1.19
0.25
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
30
264
1.14
0.24
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
87
1.26
0.24
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
230
2210
1.04
0.23
1.8
1.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
81
755
1.07
0.23
2.0
2.2
%
42.2
43.1
—
10
103
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
541
5277
1.03
0.23
1.6
1.7
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
92
0.76
0.22
1.6
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
58
535
1.08
0.22
1.2
1.1
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
16
188
0.85
0.21
2.4
2.0
umol/l
20.5
16.7
0.59
16
188
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
8
103
0.78
0.21
1.4
3.7
umol/l
39.5
39.7
—
8
90
(3011288) Drugs identified in Urine by Screen method
228
2200
1.04
0.20
1.9
2.9
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
16
187
0.86
0.20
1.9
1.6
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
49
1.22
0.20
1.0
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
264
2556
1.03
0.20
4.1
4.1
mmol/l
3.9
3.8
0.16
246
2398
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
69
645
1.07
0.19
1.9
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
269
1.12
0.19
2.6
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
269
1.12
0.19
2.6
2.9
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
12
99
1.21
0.19
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
90
1.22
0.19
1.3
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
52
561
0.93
0.19
1.0
1.0
ng/l
267.1
345.3
1.23
38
390
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
25
222
1.13
0.19
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
56
602
0.93
0.19
1.1
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
31
280
1.11
0.18
1.2
1.2
g/l
42.6
38.6
1.17
20
143
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
11
132
0.83
0.18
1.3
1.1
u/ml
0.0
0.2
—
5
81
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
16
138
1.16
0.17
1.6
2.8
—
26.6
—
0
23
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
81
766
1.06
0.17
2.2
2.1
u/field
2.2
2.2
0.01
42
307
(1001926) Buprenorphine [Presence] in Urine by Screen method
257
2496
1.03
0.17
1.7
2.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
128
1334
0.96
0.16
1.1
1.1
u/ml
3.3
4.1
0.27
42
505
(3020356) Listeria sp identified in Specimen by Organism specific culture
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
8
68
1.18
0.16
3.8
2.9
g/mol
57.2
36.1
—
8
58
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
69
1.16
0.16
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
120
1252
0.96
0.16
1.1
1.1
u/ml
3.4
3.8
0.09
45
498
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
11
92
1.20
0.16
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
47
438
1.07
0.15
1.2
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
53
565
0.94
0.15
1.0
1.0
ng/l
608.8
722.0
1.51
37
382
(3045142) Bone marrow Pathology biopsy report
96
917
1.05
0.15
1.1
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
12
102
1.18
0.15
1.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
116
1207
0.96
0.14
1.2
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
11
129
0.85
0.14
1.3
1.1
—
—
—
0
0
(4198724)
33
358
0.92
0.14
1.5
2.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
76
799
0.95
0.14
1.5
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
292
2852
1.02
0.14
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
173
1677
1.03
0.14
1.5
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
29
316
0.92
0.14
2.1
3.2
mg/l
7.6
7.9
0.07
23
246
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
104
999
1.04
0.13
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
189
1837
1.03
0.13
1.4
1.5
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
52
490
1.06
0.13
1.1
1.1
u/ml
4.9
7.3
—
6
79
(3005082) Progesterone [Moles/volume] in Serum or Plasma
56
592
0.95
0.13
1.3
1.4
nmol/l
23.9
31.5
1.67
51
536
(21494434) Karyotype in Bone marrow
73
696
1.05
0.13
1.1
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
338
3315
1.02
0.12
1.4
1.3
miu/ml
233.2
230.0
0.05
164
1578
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
16
142
1.13
0.12
1.4
1.5
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
21
231
0.91
0.12
1.8
1.3
%
47.2
36.9
0.64
14
153
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
11
95
1.16
0.11
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
315
3209
0.98
0.11
1.6
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
2073
20600
1.01
0.11
1.5
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
12
105
1.14
0.11
1.2
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
54
567
0.95
0.11
1.0
1.0
ng/l
35.5
44.5
1.23
39
385
(4034850)
304
3095
0.98
0.10
11.7
9.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
28
260
1.08
0.10
1.4
1.9
e6/l
4947.5
17112.1
0.81
13
135
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
44
1.14
0.10
1.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
25
232
1.08
0.09
1.6
2.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
15
135
1.11
0.09
3.0
2.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
95
980
0.97
0.09
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
400
4054
0.99
0.09
1.4
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
190
1862
1.02
0.09
2.8
3.2
u/ml
866.6
540.1
0.25
173
1685
(3028300) Cannabinoids [Presence] in Urine
322
3268
0.98
0.09
1.6
2.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
6
56
1.07
0.08
1.2
1.4
umol/l
76.8
82.0
—
6
51
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
29
308
0.94
0.08
1.8
1.9
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
66
1.06
0.08
3.9
6.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
67
1.04
0.08
4.7
2.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
14
127
1.10
0.07
1.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
24
256
0.94
0.07
1.6
1.9
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
27
254
1.06
0.07
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
71
0.84
0.07
1.7
2.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
8
74
1.08
0.07
9.3
7.8
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
28
296
0.95
0.07
1.6
2.1
e6/l
761.6
2550.7
0.53
18
199
(3001729) Color of Synovial fluid
7
80
0.87
0.07
1.3
1.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
17
157
1.08
0.07
1.2
1.1
u/ml
0.2
2.3
—
6
35
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
13
118
1.10
0.07
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
322
3259
0.99
0.07
1.6
1.9
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
88
1.02
0.07
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
301
2975
1.01
0.06
1.6
2.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
291
2944
0.99
0.06
1.4
1.4
pmol/l
205.1
143.3
0.44
285
2862
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
111
0.90
0.06
2.7
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
29
276
1.05
0.06
1.7
1.6
ug/l
9.2
8.6
0.25
29
276
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
107
1092
0.98
0.06
1.0
1.0
u/ml
0.1
0.4
0.96
17
235
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1160
11557
1.00
0.04
7.7
6.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
10
91
1.10
0.04
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
24
251
0.96
0.04
1.1
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
39
378
1.03
0.04
3.9
5.0
u/ml
3674.8
9550.4
—
5
67
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
12
111
1.08
0.04
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
51
523
0.98
0.04
2.2
2.1
ug/l
3.0
2.6
0.24
42
444
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
20
190
1.05
0.04
1.8
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
21
200
1.05
0.03
1.1
1.1
—
192.7
—
0
11
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
12
129
0.93
0.03
1.3
1.4
%
44.5
58.2
—
6
59
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
69
703
0.98
0.03
1.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
15
158
0.95
0.02
1.1
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
51
520
0.98
0.02
1.0
1.0
u/ml
0.1
1.3
—
6
74
(3000764) Benzodiazepines [Presence] in Urine
322
3236
0.99
0.02
1.6
2.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
141
1422
0.99
0.02
1.4
1.3
mmol/l
7.0
7.2
0.37
100
1042
(44813793)
71
720
0.99
0.02
1.1
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
23
238
0.97
0.02
2.2
1.9
ug/l
2.7
3.5
0.16
13
136
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
107
0.93
0.02
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
753
7546
1.00
0.01
2.9
2.6
ml/min/173m2
64.5
66.8
0.93
340
2995
(3026692) Albumin [Mass/volume] in Peritoneal fluid
21
203
1.03
0.01
1.2
1.4
g/l
15.2
12.6
0.62
15
157
(40768795) Lymph node Pathology biopsy report
98
972
1.01
0.01
1.1
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
44
433
1.02
0.01
1.3
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
17
176
0.97
0.00
1.4
1.1
—
—
—
0
0
(44806420)
24
246
0.98
0.00
2.8
2.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
70
694
1.01
0.00
1.3
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
15
147
1.02
0.00
2.3
2.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
54
536
1.01
0.00
2.1
2.0
ug/l
5.4
3.7
0.36
47
468
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
56
555
1.01
0.00
1.2
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
30
299
1.00
0.00
1.7
2.6
au/ml
222.6
99.7
—
5
41
(3032057) Clostridioides difficile [Presence] in Stool
21
211
1.00
0.00
1.5
1.9
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
86
0.93
0.00
2.5
1.4
umol/l
62.5
43.9
—
8
86
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
30.4
—
0
8
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008896) Cortisol [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
5
59
0.85
0.00
1.0
1.0
u/ml
6.0
15.3
—
5
47
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
8
81
0.99
0.00
1.0
1.0
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
7.2
—
1.4
—
0
5
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
82
0.98
0.00
1.3
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
9
92
0.98
0.00
3.1
2.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint THYROTOXICOSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| THYROTOXICOSIS | 1.218 [1.12, 1.33] | < 0.001 |
| Birth year | 0.993 [0.99, 1.0] | 0.103 |
During the follow-up period (1.1.1998 — 31.12.2019), 6988 out of 42750 females with THYROTOXICOSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| THYROTOXICOSIS | 1.423 [1.28, 1.58] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.017 |
During the follow-up period (1.1.1998 — 31.12.2019), 2308 out of 10455 males with THYROTOXICOSIS died.
Mortality risk
Mortality risk for people of age
years, who have THYROTOXICOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.107% | 0.312% |
| 5 | 0.702% | 1.743% |
| 10 | 1.649% | 4.371% |
| 15 | 3.151% | 8.243% |
| 20 | 5.552% | 13.497% |
Relationships between endpoints
↥Index endpoint: THYROTOXICOSIS – Thyrotoxicosis
GWS hits: 37
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data